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ABSTRACT 
The prevalences of childhood overweight and allergic diseases have increased in parallel during the 
last decades. The overall aim of this thesis was to investigate the associations between overweight 
(maternal and childhood) and allergic diseases, as well as lung function, throughout childhood up to 
adolescence. In addition, we investigated the validity of self-reported height, weight and 
corresponding body mass index (BMI) among Swedish adolescents.  
All studies were based on the BAMSE study, a population-based birth cohort of 4,089 children 
followed until age 16 years. Maternal BMI was obtained from the Swedish medical birth register, 
while childhood BMI was measured at clinical investigations, collected from child and school 
health care records and self-reported. Allergic diseases were assessed by repeated questionnaires 
regarding symptoms and medications, while allergic sensitization to inhalant allergens was defined 
by the presence of specific immunoglobulin E (IgE)-antibodies in blood. Lung function was 
measured by spirometry at 8 and 16 years and by impulse oscillometry (IOS) at 16 years.   
The results of Study I showed that maternal BMI in early pregnancy was associated with asthma, 
but not rhinitis, eczema or allergic sensitization in the offspring up to 16 years. The association was 
strongest for persistent asthma, while no increased risk was observed for transient asthma. 
Categorization of maternal BMI showed that maternal obesity, but not overweight, was significantly 
associated with childhood asthma. However, the child’s own weight status could partly explain the 
observed association between maternal BMI and asthma in the offspring.  
In Study II, we found that girls with persistent asthma had a higher BMI and an increased risk of 
overweight throughout childhood, compared to girls without asthma. Girls with transient asthma 
had an increased risk of overweight at ages 4-7.9 years, whereas girls with late-onset asthma had a 
tendency towards an increased risk of overweight at age ≥15 years. In boys, the difference in BMI 
between children with and without asthma was smaller, and no consistent association was observed 
between asthma phenotypes and overweight. 
In Study III, we observed that overweight and obesity at age 8 years were associated with increased 
forced vital capacity (FVC) and to some extent forced expiratory volume in one second (FEV1), but 
reduced FEV1/FVC ratios at 8 and 16 years. The strongest association with FEV1/FVC was 
observed for persistent overweight at both 8 and 16 years, whereas no significant association was 
found for transient overweight. Cross-sectional analyses of IOS showed that overweight and obesity 
were associated with higher peripheral airway resistance and reactance at 16 years. 
The result of Study IV showed that self-reported and measured height and weight were highly 
correlated at 16 years (r=0.98 for height, r=0.96 for weight). On average, self-reported weight was 
underreported by 1.1 kg and height was overreported by 0.5 cm, leading to an underestimation of 
BMI by 0.5 kg/m2. The accuracy of self-reported BMI was somewhat lower among girls and among 
overweight and obese participants, compared to normal weight participants.  
Our results suggest that maternal and childhood overweight and obesity are associated with asthma 
and evidence of airway obstruction in children and adolescents. The association between maternal 
BMI and asthma may, to some extent, be mediated through childhood overweight and seems to be 
explained by non-allergic mechanisms. In addition, we conclude that web-based self-reported BMI 
can be used as a valid, quick and cost-effective alternative to measured BMI among Swedish 
adolescents. The accuracy however declines with increasing BMI, and is somewhat lower among 
girls compared to boys. 
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1 BACKGROUND 
1.1 CHILDHOOD ALLERGIC DISEASE 
1.1.1 Introduction to childhood allergic disease 
The prevalence of allergic disease (here referred to as asthma, rhinitis, eczema and food 
allergy) increased rapidly during the second half of the 20th century, and currently affects 
30-40% of the population.1 The concept of the “allergic march” is sometimes used to 
describe the typical sequence of allergic disease progression throughout childhood, from 
food allergy and eczema in infancy and early childhood to asthma and rhinitis in later 
childhood.2 However, new onset and remission of allergic disease also occur continuously 
throughout childhood, and disease development in individuals does not always follow the 
“allergic march”.3 Although a large proportion of children with early allergic disease grow 
out of their symptoms, some persist into more severe disease. In children, the prevalence of 
asthma is estimated at around 7-9%, rhinitis around 9-15% and eczema around 15-20%, 
although large variations are seen across populations, ages and definitions.1, 4-7 In a Swedish 
population-based study, around 30% of the children suffered from any allergic disease 
(asthma, rhinitis or eczema) at 12 years of age, and a large proportion had more than one of 
these diseases.6  
Allergic disease is associated with sleep disturbances, missed school-days, lower school 
performance and reduced quality of life.1, 8-11 On a societal level, these diseases give rise to 
extensive health care costs and lost productivity.9 To effectively prevent and reduce the 
burden of allergic disease, it is important to identify modifiable risk factors. The main focus 
of the present thesis is to examine the role of maternal and childhood overweight for the 
development of allergic disease (in particular asthma) from birth to adolescence.   
1.1.2 Development of allergic sensitization 
Allergic disease can be classified as immunoglobulin E (IgE)-mediated and non-IgE-
mediated disease. The former is characterized by hyperreactivity of the immune system to 
otherwise harmless substances (allergens) in environment. The sensitization process (i.e. 
initiating the production of IgE antibodies) starts when an allergen enters the epithelial 
barrier of the skin, airway or gut for the first time. This process may be facilitated by a 
dysfunctional epithelial barrier, which is typically caused by genetic or environmental 
factors.12, 13 The allergen is taken up by the dendritic cell (antigen presenting cell) and is 
presented to the naïve T-cell at the lymph node.13 Through communication with cytokines, 
the naïve T-cell develops into a Th2 cell, which stimulates B-cells to produce allergen-
specific IgE-antibodies. The specific IgE-antibodies are distributed systemically and bind to 
the surface of mast cells in the airway or nasal mucosa. The next time an individual is 
exposed to the allergen, it binds to the specific antibody on the mast cell. This leads to mast 
cell activation and degranulation characterized by the release of histamine and other 
inflammatory substances. The inflammatory substances cause smooth muscle contraction, 
mucous secretion and vasodilation, which gives rise to the typical allergic symptoms that 
may be specific to the tissue where the allergic reaction occur (e.g. runny nose or 
bronchoconstriction).12 For non-IgE mediated disease, other pathophysiological 
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mechanisms related to genetics, viral infections or environmental factors are of 
importance.14, 15 
1.1.3 Definitions and diagnosis 
1.1.3.1 Asthma 
Asthma is characterized by airway inflammation, resulting in narrowing of the airways with 
reoccurring symptoms such as coughing, wheeze, dyspnea and shortness of breath. 
Asthmatic airways are hyperreactive and may be triggered by inhaled substances such as 
allergens or irritants (e.g. tobacco smoke or cold air), physical activity or infections. 
Asthma is a heterogeneous disease, which may be classified into various phenotypes.16 In 
accordance with the reasoning above, asthma can be divided into allergic (IgE-mediated) 
and non-allergic (non-IgE-mediated) disease. Allergic asthma is most common and is 
(typically) defined by the presence of specific IgE-antibodies to allergens such as pets or 
pollen.17 Allergic asthma is often characterized by airway and systemic eosinophilic 
inflammation.  
Asthma is diagnosed by symptom history, sometimes in combination with lung function 
and/or hyperreactivity tests. In epidemiological studies, asthma is commonly defined by 
questionnaire-reported symptoms, medication or doctor’s diagnosis. In small children, 
asthma is difficult to diagnose, as similar symptoms often present during respiratory tract 
infections in early life. A large proportion of young children who show asthma symptoms 
during infection will outgrow their symptoms by school-age.18  
Asthma treatment often includes short- and long-acting beta2 agonists and inhaled 
corticosteroids to counteract airway inflammation. Additional treatment with 
antileukotriens or other asthma drugs may be needed for more difficult-to-treat asthma. 
Long-term asthma with chronic inflammation can cause airway remodeling with permanent 
airflow limitations and optimal treatment is therefore important to reduce the risk of 
irreversible impairment.18 
1.1.3.2 Rhinitis 
Rhinitis is characterized by inflammation in the nasal epithelium causing rhinorrhea, 
sneezing, and blocked or itchy nose. Allergic rhinitis is defined by the presence of IgE-
antibodies against allergens in blood, whereas patients with non-allergic rhinitis may react 
to irritants or other non-allergic triggers.4 Clinically, rhinitis is diagnosed by symptom 
history, nasal examination and IgE-sensitization tests.4 In epidemiological studies, rhinitis 
is commonly defined by symptoms in the absence of an upper respiratory tract infection, 
sometimes in combination with exposure to allergens such as pollen or pets.  
1.1.3.3 Eczema 
Eczema is an inflammatory disease of the skin characterized by dry skin and itchy rash, 
caused by skin barrier dysfunction and/or a hyper-reactive immune response.19 Eczema 
symptoms are relapsing and often present at age-specific locations. Clinically, eczema is 
diagnosed through visual inspection and defined according to certain diagnostic criteria.20 
In epidemiological studies, eczema is usually defined based on questions regarding 
symptoms, doctor’s diagnosis and specific treatment.  
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1.1.3.4 Allergic sensitization 
Allergic sensitization is determined by the ability to develop IgE-antibodies to specific 
allergens. Among Swedish children, pollen, furred animals and certain foods are examples 
of common allergens to be sensitized against. During childhood, the prevalence of 
sensitization to foods such as milk and egg have been shown to decrease from pre-school 
age up to adolescence, whereas the prevalence of sensitization to inhalant allergens have 
been shown to increase.21 Allergic sensitization is measured by the presence of IgE-
antibodies in blood or by a skin prick test. High levels of IgE-antibodies increase the 
likelihood of symptoms upon allergen exposure, but many individuals are sensitized 
without showing any allergic symptoms.13   
1.1.4 Risk factors 
Allergic diseases are multifactorial and appear to be caused by a combination of genetic 
and environmental factors. Heritability of allergic disease is estimated to around 60-80%, 
and a number of specific gene variants have been found to increase the risk of disease.22, 23 
One such example is the filaggrin gene, in which loss-of-function mutations have been 
associated with skin barrier dysfunction and increased the risk of eczema.24 Parental allergy 
is a strong risk factor for allergic disease. However, the associations have been reported to 
be somewhat more pronounced for maternal, compared to paternal allergy, indicating that 
non-genetic factors such as in-utero programming are also important.25, 26 
Second hand tobacco smoke exposure is one of the most established environmental risk 
factors for asthma, and may also increase the risk for other allergic diseases.27 Both 
maternal smoking during pregnancy and second hand smoke exposure during childhood 
have been associated with wheeze and asthma in children.27, 28 Air pollution and indoor 
mold and dampness are other environmental risk factors that have been linked to asthma 
and allergic disease in children.29, 30  
The prevalence of allergic disease, including asthma, rhinitis and allergic sensitization are 
lower among children raised on a farm and in rural, compared to urban areas.31-33 In 
addition, large family size and early day-care attendance have been shown to reduce the 
risk of asthma and allergic sensitization, although the risk of transient wheeze in early life 
may be increased.34-36 These observations have been proposed to be explained by the 
hygiene hypothesis, which suggests that a diverse exposure to bacteria and parasites in 
infancy is important for immune function development.37, 38 In contrast, some viral 
infections in infancy such as the respiratory syncytial virus and rhinovirus have been shown 
to increase the risk of asthma.39 However, it is unknown whether these associations are 
causal or explained by increased susceptibility in these children.  
Maternal factors during pregnancy such as obesity (described under section 1.4), diet, 
certain medication and stress have also been suggested to contribute to the risk of asthma.40 
Although evidence is conflicting for many of the dietary factors, a meta-analysis of 32 
studies observed that higher maternal intake of vitamin D, vitamin E and zinc during 
pregnancy were associated with reduced risk of wheeze in childhood.41 In contrast, no 
association was found with asthma or for intake of other nutritional factors. 
 4 
Birth weight and gestational age have also been shown to influence the risk of asthma, 
which may be explained by suboptimal airway and lung development in children born 
prematurely or with low birth weight. A meta-analysis of almost 150,000 children observed 
that preterm birth was associated with an increased risk of asthma independent of birth 
weight, while the association for birth weight was explained by gestational age at birth 42. 
In addition, caesarian section (CS) has been suggested as a potential risk factor for asthma 
due to lack of exposure to certain microbes that are normally transferred during vaginal 
delivery. However, a register based cohort of 87,500 Swedish sibling pairs showed that 
emergency, but not elective CS, increased the risk of asthma medication in the child. These 
results suggest that indications for emergency CS (such as fetal respiratory stress or 
maternal complications), rather than the lack of microbe exposure, may explain the 
association between CS and asthma.43 Both preterm birth44, 45 and CS46 are more common 
among obese mothers, compared to normal weight mothers, and these factors may also act 
as potential mediators in the observed association between maternal obesity and childhood 
asthma.  
Factors in early childhood may also contribute to the risk of allergic disease. Breastfeeding 
has been shown to reduce the risk of asthma symptoms in early childhood, but the 
protective effect seems to diminish over time.47, 48 Early introduction of allergenic foods, 
such as peanut and egg, was previously thought to increase the risk of allergic disease, but 
today is suggested to be important for inducing oral tolerance in high risk children.49 Rapid 
growth in infancy and early childhood have also been found to increase the risk of asthma, 
in particular catch-up growth among low birth weight children.42  
Since allergic disease continues to develop throughout childhood, lifestyle and 
environmental factors beyond infancy or early childhood may also influence the risk of 
disease. For example, childhood overweight and obesity have been associated with asthma 
(described more under section 1.5), while there is less evidence for other allergic diseases. 
Furthermore, certain dietary factors such as intake of oily fish and antioxidants have been 
shown to reduce the risk of asthma and rhinitis up to adolescence.50, 51  
1.2 LUNG FUNCTION 
The lungs continue to develop until early adulthood52 and childhood is an important period 
for lung function development and future respiratory health. Asthma is associated with 
reduced lung function, mainly airway obstruction due to narrowing of the airways. Airway 
obstruction in children is usually reversed by bronchodilators, but may, for some 
individuals proceed into irreversible fixed airflow limitation characterized by airway 
remodeling.53 Lung function can be measured by various techniques, each providing 
somewhat different information that can complement each other.   
1.2.1 Dynamic spirometry 
Dynamic spirometry is the most widely used method to measure lung function in clinical 
and research settings. By using a spirometer, air flow and volume during a forced 
expiration following a maximal inhalation is measured. The amount of air that can be 
exhaled in the first second is referred to as the forced expiratory volume in one second 
(FEV1), which is a measure of flow and airway size. The total amount of air that can be 
exhaled during the full expiration is referred to as the forced vital capacity (FVC), and is 
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representative of lung size. The ratio between FEV1/FVC is a measure of relative airway 
size, where low values indicate airway obstruction. In both children and adults, reference 
equations have been developed to compare lung function values with regards to age, sex, 
height and ethnicity.54  
1.2.2 Impulse oscillometry 
Impulse oscillometry (IOS) is an effort-independent method that measures airway 
resistance (R) and reactance (X), and provides information about airway obstruction in the 
central and peripheral airways.55, 56 Measurements are performed during tidal breathing 
where external pressure impulses with frequencies between 5 and 35 Hz are forced upon 
the respiratory system. Higher frequencies (>20 Hz) reach the large and intermediate 
airways, whereas lower frequencies (around 5 Hz) travel deeper into the lung. For this 
reason, resistance at low frequencies reflects total airway resistance and resistance at high 
frequencies reflects large and intermediate airway resistance. The difference between these 
values (R5-20) represents peripheral airway function. Airway reactance can be viewed as the 
rebound resistance of the lung, where the area under the reactance curve (AX) represent the 
total reactance at all frequencies.56 R5-20 and AX are usually correlated in individuals.  
1.3 OVERWEIGHT AND OBESITY 
Overweight/obesity has emerged as one of the most serious public health challenges during 
the last decades and is a strong risk factor for several adverse health effects and chronic 
diseases.57 According to the World Health Organization (WHO), overweight and obesity 
are defined as “abnormal or excessive fat accumulation that may impair health”.58 The 
underlying cause of obesity is an imbalance between energy intake and expenditure, which 
may be achieved by a combination of various dietary factors, physical inactivity and 
genetic factors.59  
Body mass index (BMI), calculated as weight/height2, is the most widely used measure of 
overweight and obesity. Although BMI cannot differentiate between adipose and lean tissue 
in individuals, it correlates well with body fat percentage and is linked to morbidity and 
mortality on a population level.60, 61 In adults, BMI ≥ 25 kg/m2 and ≥ 30 kg/m2 are 
generally accepted cut-offs to define overweight and obesity, respectively.58 
1.3.1 Maternal overweight and obesity 
Maternal obesity is the most common complicating factor of pregnancy. According to the 
US National Health and Nutrition Examination Survey 2011-2012, 32% of all women aged 
20-39 years were obese.62 In Sweden, 12.4% of pregnant women were classified as obese at 
the first visit to the antenatal care unit around week 9-10 of pregnancy in 2014.63 
Maternal obesity is associated with a number of birth-related complications and health 
consequences for the mother and child. These includes maternal hypertension, gestational 
diabetes, preterm birth, infants born large for gestational age and an increased risk of 
obesity in the offspring.64      
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1.3.2 Childhood overweight and obesity 
1.3.2.1 Definition  
In children, BMI varies naturally with age and differs slightly between girls and boys. 
Therefore, sex- and age-specific reference values are used to define childhood overweight 
and obesity. Different reference values are proposed by organizations such as the WHO 
2007 BMI-for-age65, for ages 5-19 years and the Center for Disease Control and Prevention 
(CDC) 2000 BMI-for-age66, for ages 2-20 years. In addition, national reference values are 
frequently used to define overweight and obesity in children. In general, overweight and 
obesity are defined as the 85th and the 95th percentile and above, respectively (e.g. CDC 
2000), or by +1 and +2 standard deviation scores (e.g. WHO 2007).  
In order to provide a standard international definition of childhood overweight and obesity, 
the International Obesity Task Force (IOTF) constructed centile curves based on nationally 
representative surveys from Brazil, Great Britain, Hong Kong, the Netherlands, Singapore 
and the United States (US).67, 68 The curves were calculated to pass through BMI 25 kg/m2 
and 30 kg/m2 at 18 years; therefore corresponding to the adult cut-offs for overweight and 
obesity. Some years later, cut-offs for thinness corresponding to BMI 18.5 kg/m2, 17 kg/m2 
and 16 kg/m2 at age 18 years (thinness grade 1, 2 and 3) were also published.69 The IOTF 
reference values were argued to be more internationally representative and less arbitrary 
compared to previous reference values.    
The prevalence of overweight and obesity in children is dependent on reference method, 
where higher prevalences are obtained by the WHO, compared to the IOTF classification.70 
A comparison of the performance between the WHO 2007 and the IOTF 2012 classification 
system to predict overweight and obesity at 18 years based on BMI at 10 years showed that 
the WHO classification system had a higher sensitivity (captured more cases), while 
specificity was somewhat higher for IOTF (included less non-cases).71 
1.3.2.2 Measurements (self-reported vs measured) 
The prevalence of childhood overweight and obesity may also depend on whether weight 
and height are directly measured or reported by the parent or the child. In large 
epidemiological studies, self-reported or parental-reported weight and height are often used 
due to cost-efficiency. However, accuracy of exposure measurements is crucial in 
epidemiological studies, and the validity of self-reported weight and height should be 
considered before it is used. In general, self-reported weight is somewhat underreported, 
while self-reported height is slightly overreported, leading to an underestimation of BMI.72 
Overweight and obese individual tend to underreport weight to a higher extent than normal 
weight individuals, and females tend to underreport weight more than males.72  
The validity of self-reported weight and height may depend on factors such as age, gender, 
geographical region and ethnicity, and it is important to assess validity within the specific 
population where the use is intended. Validity may also vary over time and by methods of 
data collection. Questionnaires can be distributed through the web or by paper, and may be 
answered in school or in the home environment. This may impact on participation rate, but 
also the perception of anonymity, parental involvement and the possibility to check weight 
and height before answering the questionnaire.     
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During adolescence, the accuracy of self-reported BMI may be particularly low because of 
rapid changes in body size and composition. Also, adolescents may be more concerned over 
body ideals, which could influence their willingness to report according to what is more 
socially accepted.  
1.3.2.3 Occurrence 
A recent pooled analysis of 2,416 studies of 31.5 million children aged 5-19 years 
examined global trends in childhood underweight, overweight and obesity, based on 
measured weight and height using the WHO 2007 reference.57 The results showed that the 
global age-standardized prevalence of overweight (including obesity) increased between 
1975 and 2016, from 4.0% to 17.5% in girls and from 4.6% to 19.2% in boys. For obesity, 
the corresponding prevalence increased from 0.7% to 5.6% in girls and from 0.9% to 7.8% 
in boys. Large regional differences were observed where the prevalence of obesity ranged 
from around 1-3% in many African and some Asian countries to >20% in the US, New 
Zealand and some Middle East countries in 2016. The highest prevalence was reported in 
some small South Pacific and Indian Ocean islands, for example the Cook Islands and 
Nauru, with >30% childhood obesity.  
In Europe, the prevalence of childhood obesity varied and was the lowest in some parts of 
the northern and eastern Europe (around 5% in girls and 8-10% in boys in for example 
Sweden, Denmark, and Estonia) and highest in southern Europe (around 10% in girls and 
15% in boys in for example Italy, Greece and Portugal) in 2016. In Sweden, the prevalence 
of overweight (including obesity) was 22.1% in girls and 25.1% in boys in 2016, and the 
prevalence of obesity was 4.7% in girls and 8.5% in boys.57 In many high income countries, 
the rising trend in BMI among children and adolescents has plateaued since around the year 
2000, whereas it has increased rapidly in some parts of Asia.57 However, it has been 
debated whether the reported stabilization in the obesity epidemic is real or explained by 
bias or misinterpretation of the data.73 This was further highlighted in a recent investigation 
based on the US National Health and Nutrition Examination Survey, which observed an 
increase in the overall prevalence of childhood overweight and obesity, with a sharp 
increase in obesity from 2015-2016 in the age group 2-5 years.74  
In high income countries, an inverse gradient between socioeconomic status and childhood 
obesity has been observed.75 For example, a study on 3,492 7-9 year old children from 
western Sweden, found large differences in obesity prevalence (IOTF reference) with 0% in 
girls and 1.6% in boys in high education areas, compared to 6.8% in girls and 3.9% in boys 
in low education areas.76 
1.4 ASSOCIATION BETWEEN MATERNAL OVERWEIGHT AND CHILDHOOD 
ALLERGIC DISEASE 
Maternal BMI may influence the risk of childhood allergic disease through several potential 
mechanisms. Maternal obesity is associated with fetal inflammation, epigenetic 
modifications and altered gut colonization, which may influence fetal immune system and 
lung development.77-79 An association between maternal obesity and childhood allergic 
disease may also be explained by birth- or pregnancy-related complications (e.g. gestational 
diabetes, hypertension or preterm birth) or by shared genetics or lifestyle factors such as 
diet or physical activity.64, 79  
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A growing body of epidemiological evidence suggests that pre- or early pregnancy BMI is 
associated with wheeze and asthma in the offspring,80 while very limited evidence exists on 
the potential association with other allergic diseases. Moreover, the majority of previous 
studies on wheeze or asthma followed children up to preschool age81-87 or early school 
age88-91 and there is less knowledge on whether these associations persist into adolescence. 
Due to the short follow-up and lack of longitudinal outcome assessments, there is limited 
evidence regarding the timing and onset of asthma in relation to maternal BMI. In one 
study, maternal BMI and adiposity was associated with transient, but not persistent wheeze 
up to age 6 years,90 whereas another study reported strongest association with late-onset 
wheeze up to age 7 years.88 
At the time Study I was published, two previous studies had examined the association 
between maternal BMI and wheeze or asthma in the offspring up to adolescence.92, 93 In a 
Finnish cohort of almost 7,000 adolescents, maternal pre-pregnancy BMI was associated 
with asthma and wheeze at age 15-16 years, but only among children without parental 
history of atopy.93 In the second study, Lowe and colleagues investigated the association 
between maternal obesity in early pregnancy and dispensed inhaled corticosteroids (as a 
proxy for asthma) in a register-based study of more than 400,000 Swedish children up to 
age 16 years.92 The overall results showed that maternal obesity was associated with 
dispensed corticosteroids, whereas the association was only significant among girls in the 
age-group 13-16 years. In sibling-pair analyses, no association was observed between 
maternal obesity and corticosteroids, indicating that shared genetic or environmental risk 
factors may explain the observed association. For instance, overweight in the offspring, 
which may be caused by shared dietary and other lifestyle factors, could be a mediator in 
the association between maternal obesity and childhood asthma, but was not available for 
analysis in this register-based study.  
1.5 ASSOCIATIONS BETWEEN CHILDHOOD OVERWEIGHT AND ASTHMA 
AND LUNG FUNCTION 
In 1999, Camargo and colleagues published the first prospective study on BMI and asthma 
where they showed that obesity was associated with an increased risk of incident asthma 
among adult women in the Nurses’ Health Study.94 Shortly after, this association was also 
confirmed in longitudinal studies in children,95-98 although some of these studies observed 
an association only in boys98, and others only in girls95. For example, among 600 children 
from the Tucson Children’s Respiratory Study, Castro-Rodriguez and colleagues observed 
that girls, but not boys, who became overweight or obese between 6-11 years had an 
increased risk of developing asthma symptoms at age 11 or 13 years.95   
Ever since these initial longitudinal studies, an increasing number of studies have reported 
similar associations between obesity and asthma in children.99-102 Two meta-analyses, each 
including six prospective child cohorts, found that overweight was associated with a 19% 
and 35% higher risk of asthma, respectively, while corresponding numbers for obesity were 
102% and 50%.103, 104 One of these meta-analyses found stronger associations in boys, 
whereas the other observed inconsistent results regarding gender differences.  
Despite the large amount of studies on childhood obesity and asthma, there are still 
inconsistencies regarding the temporal association and the timing and onset of obesity or 
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weight gain. Some studies indicate that rapid weight gain in infancy is most important for 
asthma,105-107 whereas others have shown that high BMI in early life does not increase the 
risk of asthma in school-aged children that develop normal weight.108, 109 Only a few 
prospective cohorts have followed children with repeated BMI measurements throughout 
childhood, and BMI development in relation to asthma onset and persistence up to 
adolescence have not been previously investigated.  
The association between obesity and asthma may be explained by several potential 
biological mechanisms, many of them which are similar to the suggested mechanisms 
behind the association between maternal BMI and childhood asthma. For example, chronic 
airway and systemic inflammation, epigenetic modifications or altered gut microbiota have 
been proposed as possible explanatory factors.110, 111 Most studies on obesity and asthma 
have found stronger associations with non-IgE-mediated, compared to IgE-mediated 
asthma,112, 113 and no or inverse associations with airway eosinophilic inflammation,114, 115 
suggesting that the mechanisms are not mediated through allergic pathways. The possibility 
that the association between obesity and asthma may be explained by over diagnosis or 
confounded by shared genetics, prenatal- or birth-related factors (e.g. maternal BMI, 
maternal dietary factors, breastfeeding, preterm birth or mode-of delivery) or by lifestyle 
factors in childhood have also been discussed.110 In addition to obesity being a risk factor 
for asthma, the reverse has also been observed, in that asthma increase the risk for 
obesity.116 
Another potential mechanism by which obesity may influence asthma is through effects on 
lung function. Most studies in children117-120 have shown that overweight and obesity are 
associated with airway obstruction (decreased FEV1/FVC), while FEV1 and FVC are 
unaffected or increased (also referred to as dysanaptic growth121). However, it is unknown 
whether the dysanaptic pattern observed among overweight and obese children is of clinical 
importance or part of normal physiology. Studies combining spirometry with other lung 
function measures could provide more insight into the physiological mechanisms behind 
the obesity and lung function association in children. 
From a public health perspective, it is important to investigate whether any influence of 
overweight on lung function is reversible. However, the majority of studies on overweight 
and lung function in children are cross-sectional, and have not been able to analyze 
temporal changes in BMI in relation to lung function. Therefore, large prospective studies 
with repeated exposure assessments are needed to fully explore these associations in 
childhood.     
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Figure 1.1. Illustration of some of the proposed mechanisms and explanatory factors for an 
association between obesity and asthma in children.110, 122, 123 However, there are many other 
possible pathways. GERD: gastroesophageal reflux disease. 
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2 AIMS 
 
The overall objective of this thesis was to study the associations between overweight and 
allergic diseases, in particular asthma, throughout childhood up to adolescence, including 
the role of maternal BMI, and the influence on lung function.  
In addition, we aimed to investigate the accuracy of self-reported weight and height among 
Swedish adolescents, in order to evaluate whether this information can be used to define 
BMI status among adolescents.      
The specific aims were: 
I. To examine the association between maternal BMI in early pregnancy and asthma, 
rhinitis, eczema and allergic sensitization in the offspring up to 16 years of age. 
II. To investigate BMI development and the risk of overweight from birth to 
adolescence in relation to asthma phenotypes. 
III. To study the association between overweight and lung function, including 
peripheral airway function from school-age to adolescence.  
IV. To validate self-reported height, weight and corresponding BMI among Swedish 
adolescents at age 16 years. 
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3 MATERIAL AND METHODS 
3.1 THE BAMSE BIRTH COHORT 
All studies within the thesis are based on the BAMSE (Swedish acronym for Children, 
[Barn], Allergy, Milieu, Stockholm, Epidemiology) study. The BAMSE study is an 
ongoing population-based prospective birth cohort with the primary aim to study risk 
factors for development of allergic disease in children. 
3.1.1 Recruitment 
Newborn children were recruited from child health care centers in four areas of Stockholm: 
the municipalities Järfälla, Solna, Sundbyberg and northwest parts of the inner city 
(Norrmalm and Vasastaden) (Figure 3.1) between February 1994 and November 1996. The 
specific areas were chosen in order to represent a varied distribution of socioeconomic 
factors and housing conditions. Out of 7,221 children born in the study area during the 
recruitment period, 5,488 were eligible according to the inclusion criteria (Figure 3.2). The 
final cohort consisted of 4,089 children (50.5% boys), i.e., 75% of eligible, whose parents 
answered a baseline questionnaire when the children were on average two months old. 
Figure 3.1. Map of the BAMSE study area. Maps adapted from ©OpenStreetMap contributors, 
created by Erica Schultz. 
In order to evaluate the representativeness of the study population, non-responders of the 
initial survey and actively excluded families were sent a short questionnaire on selected 
exposures and parental allergic disease in 1996. The response-rate of the questionnaire was 
83% for actively excluded families and 58% for non-responders. The results showed that 
the study population was comparable to non-responders and excluded children in terms of 
allergic heredity and pet ownership, however the prevalence of parental smoking was 
somewhat higher in the non-participants.124 
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3.1.2 Follow-up 
Follow-up questionnaires focusing on symptoms of the child’s health, especially allergic 
disease in the child, were sent out to the parents when the children were approximately 1, 2, 
4, 8, 12 and 16 years. The response rates were 96%, 94% 91%, 84%, 82% and 78%, 
respectively. At 12 and 16 years, the adolescents themselves were also sent a questionnaire, 
which were answered by 68% and 76%, respectively. At 4, 8 and 16 years, children were 
invited to a clinical examination including blood sampling and measurement of height, 
weight and lung function. 
  
 
 
Figure 3.2. Flow chart of recruitment and follow-up of the BAMSE cohort 
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3.1.3 Questionnaires and clinical examinations 
The baseline questionnaire covered lifestyle, socioeconomic and environmental exposures 
in the parents such as tobacco smoke and pet ownership, the child’s health and detailed 
questions regarding allergic heredity. The majority of questionnaires (84%) were answered 
by both the mother and the father together, whereas 14% were answered by the mother only 
and 2% by the father only. 
Follow-up questionnaires were focused on allergic disease in the child, including 
symptoms, medications and doctor’s diagnosis of asthma, rhinitis and eczema. At 8 years of 
age, information on dietary intake was assessed through a food frequency questionnaire 
(FFQ), filled out by the parent or the parent together with the child at the clinical 
investigation. At 8 years, information regarding participation in organized physical activity 
and parental ethnicity were also collected. Additional questions regarding physical activity 
and sedentary behavior were included in the adolescent’s questionnaire at 12 and 16 years, 
as well self-reported weight and height, pubertal status, tobacco use and self-perceived 
health. The question on self-reported height and weight was an open ended question 
formulated as “How tall are you (cm) and what do you weight (kg)?”. At 16 years, an 
additional FFQ, adapted to and validated on teenagers (TeenMeal-Q), was included in the 
adolescent questionnaire.    
All questionnaires were sent out continuously in relation to the child’s date of birth, except 
the 12-year questionnaire which was sent out at one point in time when the children were 
between 11-14 years old (mean age 12.9 years). Up to 8 years of age, paper-based 
questionnaires were used, whereas web-based questionnaires were answered by the 
majority of parents and adolescents at 12 and 16 years. As far as possible, validated 
questions that were harmonized according to the International Study of Asthma and 
Allergies in Childhood (ISAAC),125 and to the Mechanisms of the Development of Allergy 
(MeDALL)126 project (for the questionnaires at age 16 years) were used.  
Families were invited to the clinical investigation at 4, 8 and 16 years after answering the 
respective questionnaires. The median time between filling out the questionnaire and 
attending the clinical examination was 12.4 weeks at 4 years, 7.7 weeks at 8 years and 5.6 
weeks at 16 years. The examinations were performed by trained nurses and included among 
others blood sampling and measurements of height, weight and lung function (described 
under 3.2 and 3.3) at all ages. Blood samples were analyzed for allergic sensitization and 
remaining blood was stored at -80°C for subsequent analyses.  
3.2 EXPOSURE AND COVARIATE ASSESSMENT 
3.2.1 Maternal body mass index 
Maternal body mass index (kg/m2) was calculated from weight and height obtained through 
linkage to the Swedish medical birth register (MBR). The Swedish MBR was established in 
1973 and covers more than 98% of all newborn children in Sweden.127 Maternal height has 
been included in the register since 1983, and maternal weight in early pregnancy has been 
included since 1992.  
The information on maternal height and weight in early pregnancy are recorded at the first 
visit to the antenatal care center. Between 1995-1998, most women attended their first 
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antenatal visit in week 9-10 of pregnancy, and 88% were registered before 13 completed 
weeks (i.e. first trimester).128 The completeness of these variables varies across the years 
and during 1994-1996, they are available for 81-85% of the women. Evaluation of the 
MBR shows high validity of maternal height and weight in early pregnancy compared to 
medical records.128 In addition, information on weight at admission to the delivery unit is 
included in the MBR, which enables calculation of gestational weight gain. However, after 
1993, information on weight at delivery is only available for around 33-43% of the 
women128 and was therefore not used in the current project.   
Based on BMI in early pregnancy, mothers were categorized into underweight, normal 
weight, overweight and obesity, according to the WHO definition (Table 3.1).  
Table 3.1. Definition of underweight, normal 
weight, overweight and obesity in adults 
BMI category Definition, BMI (kg/m2) 
Underweight <18.5 
Normal weight 18.5-24.9 
Overweight  25-29.9 
Obesity ≥30 
  Obesity class I    30-34.9 
  Obesity class II    35.39.9 
  Obesity class III    ≥40 
3.2.2 Childhood body mass index 
Childhood BMI (kg/m2) was calculated from weight and height obtained through 
measurements, records, registers and self-reports. 
3.2.2.1 Measurements and questionnaire data in BAMSE 
At 4, 8 and 16 years, weight and height were measured in the clinical examination. Weight 
was measured with light indoor clothes to the nearest 0.1 kg and height was measured 
without shoes to the nearest 0.1 cm. Height was measured twice and the mean value was 
used for analyses. Self-reported information on weight and height was collected at 12 years 
and 16 years in the adolescent questionnaire. 
3.2.2.2 Record- and register-data 
Information on weight and length at birth were obtained from the Swedish MBR. After 
birth, Swedish children’s weight and height are monitored regularly at pre-defined ages in 
child health care and school health centers according to standard national protocols. Almost 
all children attend the child health care centers between the ages 0-5 years (99.5% of all 
registered children in Stockholm county in the year 2013).129 In the 12-year questionnaire, 
parents were asked for permission to collect information on measured weight and height 
from the child health care and school health care records. In total, 3,151 parents provided 
consent and data was received from 2,597 children for up to 10 pre-defined ages from 6 
months to 12 years of age. An overview of the available BMI data among children in the 
BAMSE cohort is presented in Table 3.2.     
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Table 3.2. Overview of the available data on body mass index among participants in 
the BAMSE cohort (N=4,089) 
  Medical birth 
register 
Health- and 
school records1 
Clinical 
investigation 
Self-
reported 
Total 
Age (y) n (%) n (%) n (%) n (%) n (%) 
0 3,960 (97)    3,960 (97) 
0,5  2,290 (56) 
  
2,290 (56) 
1  2,264 (55) 
  
2,264 (55) 
1,5  2,188 (54) 
  
2,188 (54) 
2  1,526 (37) 
  
1,526 (37) 
3  1,262 (31) 
  
1,262 (31) 
4  2,261 (55) 2,932 (72) 
 
3,274 (80) 
5  2,204 (54) 
  
2,204 (54) 
7  2,471 (60) 
  
2,471 (60) 
8  
 
2,620 (64) 
 
2,620 (64) 
10  2,239 (55) 
  
2,239 (55) 
12  2,253 (55) 
 
2,708 (66) 2,928 (72) 
16  
 
2,599 (64) 3,057 (75) 3,107 (76) 
1Exact age at measurement was not available. Age varied with ± 2 w at 0,5 years, ± 4 
w at 1 and 1.5 years, ± 6 months at 2-5 years and 6 m to + 11 m at 7, 10 and 12 years 
3.2.2.3 Definitions of BMI categories 
Reference values from the International Obesity Task Force67-69 were used to categorize 
children into underweight/thinness, normal weight, overweight and obesity (Studies I, III 
and IV). Before 2 years of age, the gender-specific 85th percentile in the BAMSE cohort 
was used to define high BMI. In Study II, overweight was defined as the gender specific 
85th percentile of BMI for pre-defined age-groups within the cohort.   
3.2.3 Definitions of covariates 
A description of the covariates in the individual studies together with their definitions are 
found in Table 11.1 in the appendix.  
3.3 DEFINITIONS OF HEALTH OUTCOMES 
3.3.1 Allergic disease 
Allergic disease (asthma, rhinitis and eczema) were defined based on parental questionnaire 
reports, except in Study III where we used adolescents reports at 16 years to define asthma 
symptoms and medication. A combination of a number of symptoms as well as medication 
or reported doctor’s diagnosis were generally used to define allergic disease. The definition 
of asthma in BAMSE is somewhat more stringent compared to the definition used by the 
Swedish pediatric allergy section, which require three episodes of wheeze before the age of 
two years (one episode if IgE-mediated or in combination with eczema, food allergy or 
allergic heredity) and one episode at age two years and older.130 For example, in BAMSE, 
asthma at one and two years was defined as at least three episodes of wheeze in the last 12 
months in combination with signs of bronchial hyperreactivity without concurrent upper 
respiratory infection and/or treatment with inhaled corticosteroids (Table 3.3).  
Phenotypes of asthma were defined based on onset and remission of disease (Table 3.3). 
Prevalent disease was defined as fulfilling the definition of the specific outcome at each 
age, and incident disease was defined as fulfilling the definition of the specific outcome at 
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each age, without fulfilling it at any previous age. Age-specific definitions of all allergic 
diseases are described in Table 3.3.  
Table 3.3. Definitions of allergic outcomes 
Variable Definition Study 
ASTHMA 
1 year At least 3 episodes of wheeze after 3 months of age in 
combination with treatment with inhaled glucocorticosteroids 
and/or signs of bronchial hyperreactivity without concurrent 
upper respiratory infection  
I 
2 years At least 3 episodes of wheeze after 1 year of age in combination 
with treatment with inhaled glucocorticosteroids and/or signs of 
bronchial hyperreactivity without concurrent upper respiratory 
infections 
I 
4, 8, 12 and 16 years  At least 4 episodes of wheeze in the last 12 months or at least 1 
episode of wheeze during the same time period in combination 
with occasional or regular treatment with inhaled 
glucocorticosteroids. 
I 
Transient asthma Fulfilling the definition of asthma at 1, 2 and/or 4 years, but not 
at 8, 12 or 16 years 
I, II 
Late-onset asthma Fulfilling the definition of asthma at 8, 12 and/or 16 years, but 
not at 1, 2 or 4 years 
I1, II 
Persistent asthma  Fulfilling the definition of asthma at 1, 2 and/or 4 years as well as 
at 8, 12 and/or 16 years 
I, II 
RHINITIS 
1 year Symptoms from eyes or nose after exposure to furred pets or 
pollen or a doctor’s diagnosis of allergic rhinitis after 3 months of 
age 
I 
2, 4 and 8 years Symptoms from eyes or nose (sneezing, a runny or blocked nose 
or itchy, red and watery eyes) after exposure to furred pets or 
pollen or a doctor’s diagnosis of allergic rhinitis after the previous 
questionnaire 
I 
12 years Symptoms from eyes or nose (sneezing, a runny or blocked nose 
or itchy, red and watery eyes) after exposure to furred pets or 
pollen in the last 12 months or a doctor’s diagnosis of allergic 
rhinitis after 10 years of age 
I 
16 years Symptoms from eyes or nose (sneezing, a runny or blocked nose 
or itchy, red and watery eyes) after exposure to furred pets or 
pollen in the last 12 months or a doctor’s diagnosis of allergic 
rhinitis after 12 years of age 
I 
ECZEMA 
1 and 2 years Dry skin in combination with itchy rash for at least 2 weeks at 
typical location (face or arm or leg extension surfaces, or arm or 
leg flexures, or wrist or ankle flexures) or doctor’s diagnosis of 
eczema in the last 12 months. 
I 
4 years Dry skin in combination with itchy rash for at least 2 weeks 
during the last 12 months at typical location (face or arm or leg 
extension surfaces, or arm or leg flexures, or wrist or ankle 
flexures) or doctor’s diagnosis of eczema after 2 years of age. 
I 
8 years Dry skin in combination with itchy rash for at least 2 weeks 
during the last 12 months at typical location (face or arm or leg 
flexures, or wrists or ankles, or neck) or doctor’s diagnosis of 
eczema after 7 years of age. 
I 
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12 years Dry skin in combination with itchy rash for at least 2 weeks 
during the last 12 months at typical location (arm or leg flexures, 
or wrists or ankles, or neck) or doctor’s diagnosis of eczema after 
10 years of age. 
I 
16 years Dry skin in combination with itchy rash for at least 2 weeks 
during the last 12 months at typical location (arm or leg flexures, 
or wrists or ankles, or neck) or doctor’s diagnosis of eczema after 
12 years of age. 
I 
1Termed school-age onset asthma in Study I 
3.3.2 IgE-Sensitization  
IgE antibodies in blood were analyzed with ImmunoCAP (Thermo Fisher Specific, 
Uppsala, Sweden) at 4, 8 and 16 years. Sensitization to inhalant allergen was defined as a 
specific IgE ≥0.35 kU/L (technical cut-off) against cat, dog, horse, birch, timothy, 
mugwort, Dermatophagoides pteronyssinus (house dust mite) or Cladosporium (mold).    
3.3.3 Lung function 
Lung function was measured by spirometry at 8 and 16 years and by IOS at 16 years.131 
Spirometry was measured using a 2200 Pulmonary Function Laboratory (Sensormedics, 
Anaheim, CA) in 2,613 participants 8 years and a Jaeger MasterScreen-IOS system 
(Carefusion Technologies, San Diego, CA) in 2,312 participants at 16 years. Participants 
performed repeated maximal expiratory flow volume (MEFV) measurements. The curves 
were manually inspected and evaluated according to the American Thoracic Society (ATS) 
and European Respiratory Society (ERS) criteria.132 MEFV curves were considered 
acceptable if they passed visual inspection, were coded as maximal effort by the test leader, 
and the two highest FEV1 and FVC readings were reproducible according to the ATS/ERS 
criteria. FEV1 and FVC were analyzed using Global Lung function Initiative z-scores which 
accounts for sex and height.54 FEV1/FVC ratios were calculated and expressed as 
percentages.  
 
The IOS measurements were performed using a Jaeger MasterScreen-IOS system 
(Carefusion Technologies, San Diego, CA) in 2462 participants at 16 years. Participants 
were instructed to tightly seal their lips around the mouthpiece while performing tidal 
breathing. Each participant performed at least two measurements, and after visual quality 
inspection, the mean value of resistance between 5 Hz and 20 Hz (R5-20) and the square root 
of the area under the reactance curve (AX0.5) were used for analyses. 
3.3.4 Fractional exhaled nitric oxide 
Fractional exhaled nitric oxide (FeNO) was analyzed as a measure of eosinophilic airway 
inflammation. FeNO (expressed as parts per billion [ppb]) was measured at 16 years using 
an online chemiluminescent (CLD88) analyzer (ECO Medics AG, Duernten, Switzerland) 
at an expiratory flow of 50 mL/s (FeNO50) according to ATS/ERS guidelines.133  
3.3.5 Biomarkers of inflammation 
Peripheral blood samples were analyzed for eosinophil and neutrophil cell count at 16 years 
(109 cells/L) as biomarkers for systemic inflammation. These analyses were performed at 
the Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, 
Sweden. 
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3.4 STUDY POPULATIONS AND STUDY DESIGN 
All studies in this thesis have an observational study design (i.e. the exposure status is 
outside the control of the researcher). Studies I-III are longitudinal (i.e. the outcomes 
and/or the exposures are assessed repeatedly over time). Study IV is a validation study, 
evaluating self-reported height, weight and BMI in relation to measured values at one point 
in time. Depending on the specific study aim and inclusion criteria, each study consist of 
different study populations. 
In Study I, children with available information on maternal BMI in early pregnancy and 
information on an outcome from at least three follow-up questionnaires were included. In 
total, 3,294 children were included in the analyses on allergic disease outcomes and 2,850 
children were included in the analyses on sensitization to inhalant allergens. When 
analyzing maternal BMI as a continuous variable, underweight children (n=117) were 
excluded, since there were indications of a U-shaped association between maternal BMI 
and asthma.  
In Study II, children with available information on asthma phenotypes and at least one 
BMI measurement from birth to 16 years were included, in total 2,818 children.  
In Study III, children with information on BMI and spirometry at 8 or 16 years or on IOS 
and BMI status at 16 years were included. In total, 2,889 children were included in the 
study population, however the number with available data varied for the different 
outcomes. Most children were included in the longitudinal analyses (n=2,293), where 
information on lung function was required from one time point only. Fewer children were 
included in analyses on change in overweight status between 8 and 16 years (n=1,560), 
since this analyses required information on BMI status at both 8 and 16 years. 
In Study IV, children with information on measured and web-based self-reported weight 
and height at 16 years with no more than 8 weeks between the reported and measured 
values were included. This resulted in a study population of 1,698 adolescents. In the 
analysis of potential prediction factors for differences between self-reported and measured 
BMI, complete information on all tested variables were required, and resulted in a 
subpopulation of 1,337 adolescents.  
3.5 STATISTICAL ANALYSES 
3.5.1 Main statistical methods 
The main statistical methods for association analyses in the thesis were logistic regression 
for dichotomous outcomes and linear regression for continuous outcomes. The results are 
presented as odds ratios (ORs) for logistic regression and as β-coefficients for linear 
regression, together with the 95% confidence intervals (CIs). 
For longitudinal outcomes, generalized estimating equations (GEE) were applied to the 
logistic regression analyses (association between maternal BMI and allergic disease in 
Study I and the risk of overweight in relation to asthma phenotypes in Study II) and mixed 
effect models were applied to the linear regression analyses (association between BMI 
status at 8 years and lung function up to 16 years in Study III). GEE and mixed effect 
models take into account that repeated measurements on the same individual are correlated. 
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Interaction terms between the exposures and the time variables were incorporated into the 
models to estimate age-specific associations and changes in the outcome over time. 
Multinomial logistic regression was used when the outcomes consisted of more than two 
categories (e.g. asthma phenotypes in Study I). 
Quantile regression was used to investigate associations at different percentiles of the 
outcome. Quantile regression can be used to analyze associations at any percentile of the 
dependent variable, thus allowing for varying effects over the distribution of the outcome. 
In Study II, quantile regression was used to analyze BMI at the 85th percentile as the main 
analysis (considered as high BMI/overweight) and at the median as a sensitivity analysis. 
To capture the characteristic shape of the BMI growth curve, restricted cubic splines with 
five knots were applied. Quantile regression was also used in Study III to analyze 
associations between BMI status and IOS and inflammatory markers on the median due to 
non-normally distributed data. 
In Study IV we used one-sample t-tests to compare self-reported and measured height 
weight and BMI at 16 years. Agreement was evaluated by Pearson correlation coefficients, 
and a Bland-Altman plot was used to visually investigate absolute agreement between self-
reported and measured BMI. Prediction factors for validity of self-reported BMI were 
identified through backward selection, using a p-value of <0.2 from the log-likelihood test 
to determine the model.  
3.5.2 Covariate selection 
Potential confounding factors were identified from a priori knowledge/previous literature 
(Study I and II), as well on their association with asthma phenotypes (Study II). Factors 
considered as potential mediators were additionally identified and evaluated by their impact 
on the observed associations. Specifically, overweight in the offspring was considered as a 
potential mediator between maternal BMI and offspring asthma in Study I, since maternal 
BMI is a risk factor for offspring overweight (observed OR in Study I: 2.42, 95% CI: 2.04-
2.86 at 16 years) and childhood overweight previously have been associated with asthma 
(discussed in section 1.5). In order to investigate the impact of overweight in the offspring 
on the observed associations between maternal BMI and asthma, we performed separate 
analyses adjusted for childhood overweight. Moreover, we performed a causal inference 
test at 16 years to investigate whether the association between maternal BMI and asthma in 
the offspring was explained by overweight in the offspring.  
In Study III, the final covariate model was selected based on testing whether each potential 
confounder affected the observed estimates by ≥ 10% in the main analyses. The exception 
was the adjustment for adolescent smoking when analyzing FeNO, which is known to 
affect FeNO levels. 
Effect modification was evaluated by the Wald test using an interaction term between the 
exposure and the potential effect modifier. Analyses were stratified by gender in Studies 
II-IV and by BMI status in Study IV.    
All analyzes were performed using the statistical software Stata (StataCorp, College Station 
LP, TX, USA). A p-value of <0.05 was considered statistical significant. 
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3.6 ETHICAL CONSIDERATIONS 
The BAMSE study (and each follow-up) was approved by the Ethics committee of 
Karolinska Institutet, Stockholm, Sweden. The parents of all participants provided informed 
consent and were informed that they were free to withdraw from the study at any stage.  
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4 RESULTS 
4.1 MATERNAL BMI AND ALLERGIC DISEASE IN THE OFFSPRING 
4.1.1 Descriptive results on allergic disease and maternal BMI 
The prevalences of asthma, rhinitis and eczema from ages 1-16 years (Study I) are 
presented in Figure 4.1. The prevalence of asthma averaged at around 6-7% throughout the 
follow-ups, whereas the prevalence of rhinitis increased with age to around 25% at 16 
years. Eczema was most prevalent in early childhood, but decreased from 20% at 4 years to 
around 9% at 16 years.   
Among children with available information on asthma phenotypes (n=2,436), 143 (5.9%) 
were classified as having early transient asthma, 225 (9.2%) as having school-age onset 
asthma and 155 (6.4%) as having persistent asthma. Sensitization to inhalant allergens was 
present among 356 (15.7%) of the children at 4 years, 554 (26.3%) at 8 years and 939 
(42.9%) at 16 years. 
 
 
 
The mean maternal BMI in Study I was 22.9 kg/m2 (range 14.7-44.4 kg/m2 median 22.3 
kg/m2). Maternal overweight and obesity was present in 535 (16.2%) and 126 (3.8%) of the 
participants, respectively, whereas 117 (3.6%) of the mothers were underweight (Figure 
4.2).  
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Figure 4.1 Prevalence of allergic disease among children included in Study I (n=3,294) 
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4.1.2 Associations between maternal BMI and allergic disease 
In analyses of BMI as a continuous variable, increasing maternal BMI in early pregnancy 
was associated with asthma in the offspring among mothers with a BMI ≥ 18.5 kg/m2 
(overall OR up to 16 years per 5 kg/m2: 1.23, 95% CI: 1.07-1.40 for prevalent asthma and 
1.17, 95% CI: 1.03-1.32 for incident asthma). The association was not statistically different 
between girls and boys, or between children with and without sensitization to inhalant 
allergens or allergic heredity. Age-specific analyses of prevalent asthma showed that the 
association reached statistical significance only at 2 years of age (OR per 5 kg/m2: 1.42, 
95% CI: 1.17-1.73), although increased ORs were observed also at the other ages (Figure 
4.3). No association was observed between maternal BMI in early pregnancy and rhinitis 
(overall OR per 5 kg/m2: 1.07, 95% CI: 0.96-1.19), eczema (overall OR per 5 kg/m2: 1.03, 
95% CI: 0.93-1.14) or allergic sensitization (overall OR per 5 kg/m2: 1.05, 95% CI: 0.93-
1.19) in the offspring up to 16 years.  
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Figure 4.3. Associations between maternal BMI in early pregnancy and prevalent asthma in the 
offspring at 1-16 years among children with maternal BMI ≥ 18.5 kg/m2 (n=3,177). 
Figure 4.2 Categories of maternal BMI in early pregnancy (%) in Study I (n=3,294) 
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Analyses of asthma phenotypes showed that maternal BMI was most strongly associated 
with persistent asthma (OR per 5 kg/m2: 1.31, 95% CI: 1.03-1.67). The corresponding OR 
for school-age onset asthma was 1.22, 95% CI: 0.98-1.52, whereas no association was 
observed with early transient asthma (OR per 5 kg/m2: 1.02, 95% CI: 0.77-1.36).  
Maternal BMI in early pregnancy was subsequently categorized into underweight, normal 
weight (referent), overweight and obesity and analyzed in relation to overall risk of 
prevalent asthma in the offspring up to 16 years. The results showed that maternal obesity 
was associated with asthma (OR: 1.53, 95% CI: 1.04-2.26), whereas there was no 
significant association among overweight (corresponding OR: 1.14, 95% CI: 0.90-1.45) or 
underweight (corresponding OR: 1.29: 0.83-2.01) mothers.  
The overall association between maternal BMI and asthma up to 16 years was somewhat 
attenuated and became non-significant when adjusting for overweight in the child at each 
age (OR: 1.15, 95% CI: 0.99-1.33, compared to 1.23, 95% CI: 1.07-1.40). The associations 
were mainly attenuated at ages 8 and 12 years, whereas the estimates were essentially 
unaffected at the early ages. The association between maternal obesity and asthma up to 16 
years was further attenuated and became non-significant when adjusting for overweight in 
the offspring at each age (OR: 1.24, 95% CI: 0.80-1.94, compared to 1.53, 95% CI: 1.04-
2.26), whereas the association between maternal BMI and persistent asthma was only 
slightly changed when adjusting for overweight at 16 years (OR 1.29, 95% CI: 0.98-1.70, 
compared to 1.31, 1.03-1.67). A causal inference test additionally suggested that childhood 
overweight may partly mediate the observed association between maternal BMI and 
childhood asthma at 16 years.  
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4.2 CHILDHOOD OVERWEIGHT AND ASTHMA 
4.2.1 BMI development throughout childhood 
The available BMI data and estimated percentiles of BMI development for girls and boys 
included in Study II are shown in Figure 4.4. The observed BMI development followed 
the same pattern as international surveys67, with a rapid increase in BMI during the first 
year of life. After around one year of age, BMI subsequently decreased until around six 
years of age at the median (commonly referred to as the adiposity rebound). After 
approximately six years, BMI increased with increasing age throughout the rest of 
childhood.  
 
Figure 4.4. Body mass index (BMI, kg/m2) measurments and estimated percentiles (5th, 15th, 25th, 
50th, 75th, 85th and 95th) throughout childhood among A) girls and B) boys. BMI development was 
modeled through quantile regression using splines with 5 knots. At ages 4, 8, 12 and 16 years, BMI 
from clinical investigations and questionnaires was used. At the other ages, register and health record 
data without exact age at each measurement was used. 
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4.2.2 Childhood overweight in relation to asthma  
The 85th percentile BMI in relation to asthma phenotypes are shown in Figure 4.5. Among 
girls, BMI was highest among children with persistent asthma throughout childhood, 
whereas children without asthma had the lowest BMI. Girls with transient and late-onset 
asthma had relatively similar BMI development; in general slightly higher compared to 
girls without asthma, although lower compared to girls with persistent asthma. The 
difference in BMI between girls with persistent asthma and the other asthma phenotypes 
increased with age. At 16 years, the 85th percentile BMI was 23.6 kg/m2 among girls 
without asthma, compared to 27.4 kg/m2 among girls with persistent asthma (corresponding 
to a 10.6 kg difference in weight for a female who is 167 cm tall). In boys, there were only 
small differences in BMI between children with or without asthma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5. The 85th percentile body mass index (BMI, kg/m2) throughout childhood in relation to 
asthma phenotype among A) girls and B) boys. BMI development was modeled through quantile 
regression using splines with 5 knots. 
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The associations between asthma phenotypes and overweight are shown in Figure 4.6. 
Among girls, transient asthma was associated with overweight in the age group 4-7.9 years, 
although non-significant increased odds ratios were also seen in some of the other age 
groups (Figure 4.6 A). Late-onset asthma was associated with a trend towards overweight 
in adolescence, whereas no association was observed in early childhood (Figure 4.6 B). 
Persistent asthma was significantly associated with overweight at all age groups from two 
years and onwards (Figure 4.6 C). All asthma phenotypes were associated with a tendency 
towards increased risk of overweight at birth.  
Among boys (Figure 4.6 D-F), the associations between asthma phenotypes and 
overweight were less consistent. A statistically significant association was observed 
between persistent asthma and overweight in the age-group 6 months-1.9 years, however 
increased but non-significant ORs were observed also at other ages for all three asthma 
phenotypes.  
 
Figure 4.6. Adjusted odds ratio of overweight (body mass index [BMI, kg/m2] above the 85th 
percentile [as calculated in the non-asthmatics]) for A) Transient asthma in girls, B) Late-onset 
asthma in girls, C) Persistent asthma in girls, D) Transient asthma in boys, E) Late-onset asthma in 
boys, F) Persistent asthma in boys. Analyzes were performed using generalized estimating equation 
models adjusted for allergic heredity, maternal smoking during pregnancy and/or in infancy, parental 
occupation, maternal BMI in early pregnancy, gestational age and breastfeeding. 
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4.3 CHILDHOOD OVERWEIGHT AND LUNG FUNCTION 
4.3.1  Descriptive results on lung function at ages 8 and 16 years 
Summary statistics of lung function at 8 and 16 years, as well as inflammatory markers at 
16 years are shown in Table 4.1. Between 8 and 16 years, FEV1 increased from 1,732 ml to 
2,481 ml in girls and from 1,821 ml to 4,491 ml in boys. In contrast, z-scores of FEV1 
decreased from 0.47 to -0.04 in girls and from 0.36 to -0.04 in boys, indicating an overall 
reduction in FEV1 trajectory in this dataset compared to the reference values. A similar 
pattern was observed for FVC with increased absolute values (ml) but decreased values 
relative to the reference (z-scores).             
 
               
                            
4.3.2 Association between BMI status and lung function  
BMI status (underweight, normal weight [referent], overweight and obesity) were analyzed 
in relation to lung function at 8 and 16 years. Overweight and obesity at 8 years were both 
associated with higher FVC at 8 and 16 years in girls and boys (Figure 4.7). Overweight 
was further associated with higher FEV1 in boys at both ages and in girls at 16 years, and 
obesity was associated with higher FEV1 in girls at both ages and in boys at 8 years. 
However, overweight and obesity were associated with lower FEV1/FVC in girls (-2.0%, 
95% CI: -4.0;-0.0 for obesity) and boys (-3.8%, 95% CI: -6.3;-1.2 for obesity) at 16 years, 
whereas the association did not reach statistical significance for obesity at 8 years. Thinness 
was associated with lower FVC and FEV1, but there were no clear association between 
thinness and FEV1/FVC (Figure 4.7). Cross-sectional analyses at 16 years showed that 
there was no statistically significant difference in the association between overweight 
(including obesity) and FEV1/FVC among children with or without wheeze. 
Table 4.1. Descriptive statistics of lung function and inflammatory markers among 2,889 children in the 8 and 16-
year examination 
 8 years 16 years 
 Girls Boys Girls Boys 
 N Mean (SD) N Mean (SD) N Mean (SD) N Mean (SD) 
FEV1 (ml) 920 1732.1 (256.6) 912 1820.5 (279.9) 1121 3480.5 (445.6) 933 4491.4 (650.2) 
FVC (ml) 920 1987.7 (294.1) 912 2144.5 (339.7) 1121 4033.2 (522.8) 933 5380.4 (777.1) 
FEV1/FVC (%) 920 87.3 (5.3) 912 85.2 (5.9) 1121 86.5 (6.1) 933 83.8 (6.6) 
FEV1 (z-score) 919 0.47 (0.94) 912 0.36 (0.93) 1119 -0.04 (0.91) 933 -0.04 (0.97) 
FVC (z-score) 920 0.62 (0.90) 912 0.56 (0.91) 1119 0.15 (0.91) 933 0.15 (0.96) 
     N Median (IQR) N Median 
R5-R20 (Pa·L-1·s)     1260 20.0 (55.0) 1191 15.0 (45.0) 
AX0.5 (Pa·L-1)0.5     1260 16.4 (5.8) 1190 12.6 (5.0) 
FeNO (ppb)     1044 14.0 (10.1) 1015 17.5 (13.8) 
Blood eosinophils 
(109  cells/L) 
    1225 0.1 (0.1) 1168 0.2 (0.1) 
Blood neutrophils 
(109  cells/L) 
    1225 3.5 (1.6) 1168 3.0 (1.4) 
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In particular, persistent overweight at both 8 and 16 years was associated with reduced 
FEV1/FVC at 16 years (-2.8%, 95% CI: -4.1;-1.2 in boys and -2.7%, 95% CI: -4.4;-1.1 in 
girls). Overweight at 8 years only (transient overweight) or at 16 years only (late-onset 
overweight) was associated with a tendency towards lower FEV1/FVC at 16 years, although 
the estimates did not reach statistical significance (Figure 4.8). Analyses of change in lung 
function between 8 and 16 years in relation to BMI status at 8 years showed that 
overweight, but not obesity, was associated with somewhat increased FEV1 and FVC in 
girls, but not boys. Obesity, but not overweight was associated with decreased FEV1/FVC 
between 8 and 16 years in boys, but not in girls. 
 
 
 
 
 
 
Figure 4.7. Association between BMI status (thinness [●], normal weight [♦, referent], overweight 
[▲] and obesity [■]) at 8 years and lung function (FEV1, [z-scores] FVC [z-scores] and FEV1/FVC [%]) 
up to 16 years. β-coefficients and 95% confidence intervals (CI) are estimated using mixed effect 
models (n=1,158 girls with 1,827 observations and n=1,135 boys with 1,689 observations). 
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Analyses of peripheral airway function at 16 years using the IOS technique (Table 4.2) 
showed that overweight and obesity at 16 years were both associated with higher frequency 
dependence of resistance (R5-20) and larger area under the reactance curve (AX
0.5). In 
contrast, thinness was associated with lower R5-20. Analyses of BMI status at 8 years in 
relation to peripheral airway function at 16 years resulted in somewhat weaker associations, 
although the trend was similar as compared to BMI status at 16 years.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cross-sectional analyses on biomarkers of local and systemic inflammation at 16 years 
showed no association between BMI status and FeNO. In contrast, increased blood 
neutrophil cell count were observed in overweight (0.3*109 cells/L, 95% CI: 0.03;0.57) and 
obese (0.9*109 cells/L, 95% CI: 0.24;1.56) girls, whereas no significant association was 
found in boys. In addition, blood eosinophil cell count were somewhat elevated in obese, 
but not in overweight girls, while there were no association between BMI status and 
eosinophils in boys. 
Table 4.2. Cross-sectional associations between body mass index (BMI) status and 
impulse oscillometry at 16 years (n= 1,258 girls and 1,191 boys) 
 R5-20 (Pa·L-1·s) 
 Girls Boys 
BMI category β1 95% CI p-value β1 95% CI p-value 
Thinness -15.9 -25.8;-6.0 0.002 -12.9 -21.9;-3.9 0.005 
Normal weight Referent Referent 
Overweight 32.7 24.5;40.9 <0.001 22.3 16.1;28.5 <0.001 
Obesity 56.8 38.3;75.4 <0.001 47.8 34.9;60.7 <0.001 
 AX0.5 (Pa·L-1)0.5 
 Girls Boys 
 β1 95% CI p-value β1 95% CI p-value 
Thinness -0.4 -1.4;0.6 0.42 -0.3 -1.2;0.7 0.58 
Normal weight Referent Referent 
Overweight 3.1 2.3;3.9 <0.001 1.6 0.9;2.2 <0.001 
Obesity 3.1 1.3;4.9 0.001 3.5 2.2;4.8 <0.001 
1Represent median difference in outcome compared to the reference group, calculated 
by linear regression on the median adjusted for age and height 
Figure 4.8. Association between overweight (includes overweight and obesity) status between 8 and 16 
years and FEV1/FVC at 16 years (n=840 girls and 720 boys). The point estimates represent mean 
difference in FEV1/FVC compared to the reference group (children with normal weight at 8 and 16 
years) calculated by linear regression adjusted for age and height. Children with thinness are excluded. 
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4.4 VALIDITY OF SELF-REPORTED HEIGHT, WEIGHT AND BMI 
A summary of mean self-reported and measured height, weight and corresponding BMI 
among adolescents included in Study IV are shown in Table 4.3. Overall, height was 
overreported by on average 0.5 cm and weight was underreported by on average 1.1 kg, 
leading to an underestimation of BMI by 0.5 kg/m2. Boys overreported height somewhat 
more than girls (0.6 cm vs 0.4 cm) and girls underreported weight somewhat more than 
boys (-1.5 kg vs -0.7 kg). The Pearson correlation coefficients comparing self-reported and 
measured values were 0.98 for height, 0.96 for weight and 0.94 for BMI. Similar 
coefficients were observed among boys and girls. 
Table 4.3. Summary of self-reported and measured height, weight and BMI by gender 
Anthropometrics  Self-reported, 
mean (SD) 
Measured, 
mean (SD) 
Difference, 
mean (SD) 
p-value 
Total (N=1,698)     
  Height (cm) 173.6 (9.0) 173.1 (9.0) 0.5 (1.8) <0.001 
  Weight (kg) 63.9 (11.0) 65.0 (11.5) –1.1 (2.9) <0.001 
  BMI (kg/m2) 21.1 (2.8) 21.6 (3.1) –0.5 (1.1) <0.001 
Girls (n=889)     
  Height (cm) 167.9 (6.1) 167.4 (6.2) 0.4a (1.5) <0.001 
  Weight (kg) 59.0 (8.7) 60.5 (9.2) –1.5b (2.5) <0.001 
  BMI (kg/m2) 20.9 (2.8) 21.6 (3.0) –0.6b (1.0) <0.001 
Boys (n=809)     
  Height (cm) 179.9 (7.2) 179.3 (7.2) 0.6 (2.1) <0.001 
  Weight (kg) 69.2 (10.7) 69.9 (11.7) –0.7 (3.2) <0.001 
  BMI (kg/m2) 21.3 (2.8) 21.7 (3.2) –0.4 (1.1) <0.001 
a Significantly different from boys (p=.02) 
b Significantly different from boys (p <.001) 
 
BMI was underreported to a higher extent among overweight (1.2 kg/m2) and obese (2.0 
kg/m2), compared to normal weight adolescents (0.4 kg/m2). In contrast, underweight 
adolescents overreported BMI by 0.3 kg/m2. In total 86.4% of adolescents were classified 
into the correct BMI category (underweight, normal weight, overweight or obese) using 
self-reported information on weight and height. The proportion of correctly classified were 
highest among normal weight adolescents (93.7%), followed by underweight (71.1%), 
overweight (60.2%) and obese (45.5%) adolescents. Figure 4.9 shows a Bland-Altman plot 
illustrating differences between self-reported and measured BMI in relation to measured 
BMI. Higher measured BMI was associated with increasing differences between self-
reported and measured BMI (more underreporting).  
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There was no significant association between age, parental ethnicity, parental 
socioeconomic status, physical activity, sedentary time, pubertal status, sleep duration, fruit 
and vegetable intake, tobacco use or self-perceived health and differences between self-
reported and measured BMI. Only gender (girls underreported 0.4 kg/m2 more than boys in 
the in the mutual adjusted analysis) and BMI status (overweight underreported 0.8 kg/m2 
more and obese underreported 1.5 kg/m2 more, compared to normal weight adolescents in 
the mutual adjusted analysis) were significantly associated with accuracy of self-reported 
BMI.  
  
Figure 4.9. Difference between self-reported and measured BMI in relation to measured BMI. 
The solid line represent no difference between self-reported and measured BMI. The dashed 
lines represents mean difference and ± 2 SD 
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5 DISCUSSION 
5.1 MAIN FINDINGS AND INTERPRETATIONS 
5.1.1 Maternal BMI and allergic disease in the offspring 
In Study I, we observed that maternal BMI in early pregnancy increased the risk of asthma, 
but not rhinitis, eczema or allergic sensitization in the offspring up to age 16 years. The risk 
was strongest for persistent asthma, whereas no association was found for transient asthma. 
Categorization of maternal BMI showed that maternal obesity, but not overweight, 
significantly increased the risk of asthma in the offspring. Overweight in the offspring was 
found to, at least partly, mediate the association between maternal BMI and childhood 
asthma.  
At the time Study I was initiated, a limited number of studies had investigated the potential 
role of maternal BMI before pregnancy or in early pregnancy in relation to risk of allergic 
disease in the offspring. Overall, an association between maternal BMI and asthma 
symptoms, diagnosis and medication up to preschool age or early school age had been 
observed86-88, 90, 91, however, few studies had followed children up to adolescence92, 93. In 
contrast to asthma, the risk of other allergic diseases such as eczema or rhinitis were largely 
unknown, and not all study designs permitted consideration of childhood BMI. Therefore, 
our study could contribute with new information regarding the risk of allergic outcomes in 
relation to maternal BMI.  
The results of Study I suggested that maternal BMI in early pregnancy was a risk factor for 
asthma in the offspring up to age 16 years, thereby extending the knowledge from previous 
studies. The longitudinal design and repeatedly collected information on symptoms and 
medication further gave us the possibility to investigate timing of onset and remission of 
asthma throughout childhood. Although maternal BMI was significantly associated with 
asthma at age two years only, the association was strongest for persistent asthma, while no 
increased risk was observed for transient asthma. These results highlight the clinical 
importance and indicate that maternal BMI may be associated with a more severe disease 
phenotype. Since our results were published, a meta-analysis80 and a pooled analysis of 14 
European birth cohorts up to age two years (not including our Study I)134 have confirmed 
the association between maternal BMI and childhood wheeze/asthma, whereas more studies 
are still needed to confirm our results up to adolescence.  
Regarding allergic outcomes other than asthma, the results of Study I are in line with the 
few reports of no associations with eczema, hay fever88 or allergic sensitization90, 91. Taken 
together, these results indicate that maternal BMI may impact childhood asthma by other 
mechanisms than through allergic pathways. 
Childhood obesity has been suggested to be a potential mediator in the association between 
maternal BMI and childhood asthma. Most,87, 90, 91, 93 but not all135, previous studies 
however found no or limited impact of adjustment for childhood BMI, indicating that 
independent effects (e.g. through prenatal programming) are also plausible. In contrast, 
significant mediation of childhood BMI was found in a formal mediation analysis of the 
association between maternal obesity and wheeze, but not asthma, up to age 7-8 years in 
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3,185 mother-child dyads from a Dutch birth cohort.136 The conflicting results between 
studies may be explained by age differences or that self-reported information on childhood 
BMI was sometimes used. It is possible that any potential mediating effect of offspring 
BMI differ with age since our results in Study I showed that childhood overweight 
primarily influenced the observed association at later ages. 
The association between maternal BMI and offspring asthma may be explained by several 
potential biological mechanisms, albeit most of these are speculative and more studies are 
needed to fully understand the underlying factors. Obesity is associated with low-grade 
systemic inflammation with elevated levels of pro-inflammatory cytokines, adipokines and 
hormones such as tumor necrosis factor-α, C-reactive protein, interleukin-6, leptin and 
cortisol.77, 82, 137 The increased inflammatory environment of maternal obesity has been 
suggested to cause fetal inflammation and immune dysregulation through an enhanced 
inflammatory response of the placenta.77, 138 Furthermore, both maternal BMI and dietary 
factors have been associated with epigenetic modifications in the offspring; therefore fetal 
programing may play an important role.77, 139 Maternal dietary factors such as fish intake, 
antioxidants or Vitamin D may also influence the risk of asthma through other pathways, 
although epidemiological studies have reported inconclusive results between these factors 
and childhood asthma.41 In addition, pregnancy and birth-related complications, such as 
gestational hypertension and preterm birth, have been suggested as explanatory factors, but 
did not influence the results in our study. Gestational weight gain during pregnancy has also 
been associated with wheeze and asthma in the offspring, although the results are less 
consistent compared to maternal obesity.80  
Moreover, the association between maternal BMI and asthma in the offspring may be 
explained by neonatal lung function development. A study of 2,606 children from a Dutch 
prospective birth cohort found that the association between maternal BMI and early wheeze 
was partially explained by impaired infant lung function, whereas infant lung function was 
of minor importance for the association with wheeze at later age.135 Finally, the association 
between maternal BMI and offspring asthma may be explained by the gut microbiota. The 
gut microbiota is involved in energy regulation, and altered microbiota has been observed 
in obesity.78 The microbiota is also important for immune function development and both 
maternal and fetal microbiota have been linked to wheeze and atopic outcomes in 
childhood.78, 140 Maternal flora influences fetal gut colonization through birth, where CS has 
been suggested to increase the risk of asthma, due to fetal colonization of different bacterial 
species. However, a sibling study suggested that indications for CS (such as fetal 
respiratory stress or maternal complications), rather than the lack of microbe exposure, are 
more likely to explain the association between CS and asthma.43 
5.1.2 Childhood overweight and asthma 
In Study II, we found that girls with persistent asthma had higher BMI and an increased 
risk of overweight throughout childhood, compared to girls without asthma. Girls with 
transient asthma had an increased risk of overweight in early and middle childhood, 
whereas girls with late-onset asthma had a tendency towards increased risk of overweight in 
late childhood. In contrast, no consistent associations between asthma phenotypes and 
overweight were observed among boys. 
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Extensive previous literature reviews including large prospective cohorts103, 104 and a 
Mendelian randomization study141 have linked BMI or overweight/obesity and asthma in 
childhood. A unique feature of Study II was the large number of BMI measurements from 
birth to age 16 years, which permitted us to investigate BMI development throughout the 
entire childhood in relation to asthma onset and remission. Only a few previous birth 
cohorts have followed children up to adolescence using repeated measurements of BMI. In 
the Isle of Wight cohort the risk of asthma was analyzed in relation to BMI trajectories up 
to age 18 years based on information on BMI at ages 1, 4, 10 and 18 years.142 Comparable 
to our findings, the risk of asthma at 18 years was strongest among children categorized 
into the ‘early persistent overweight’ trajectory, but was also increased among the ‘delayed 
overweight’ trajectory.142 No association between ‘early transient overweight’ and asthma 
at age 18 years was present, which is in line with a previous study from the BAMSE cohort, 
showing that current, but not early-transient overweight up to age 7 years was associated 
with an increased risk of asthma at age 8 years.108 
Some studies have suggested that rapid infant or early childhood weight gain may be most 
important for the risk of asthma development, speculating that early abnormal growth may 
impact lung or immune function during critical development periods.105, 106, 143 In Study II, 
we observed that children with persistent asthma had an increased BMI already in early 
childhood (before age two years), suggesting that early rapid weight gain and/or common 
risk factors in early life may be of importance. However, girls with late-onset asthma did 
not have an elevated BMI in infancy and later BMI may also be of importance, at least for 
late-onset asthma. The difference in BMI among girls with persistent asthma, compared to 
no asthma was present throughout childhood and seemed to increase with age, indicating 
that asthma may also influence later BMI development in girls.  
The potential bidirectional association between BMI and asthma has garnered more 
attention recently. Asthma may impact on the risk of obesity through reduced levels of 
physical activity due to symptoms during exercise. In a study of 2,171 US children, having 
an asthma diagnosis at age 5-8 years increased the risk of developing obesity during 
childhood and adolescence.116 Among Norwegian adolescents followed up to young 
adulthood, a bidirectional association between obesity and asthma was also found in males, 
but not females.144 Taken together, it may be possible that infancy and childhood weight 
gain contribute to the risk of asthma development, while asthma itself contributes to weight 
gain later in childhood. 
Among children, conflicting results have been observed regarding gender differences in the 
obesity-asthma association.103 In adults, the association between obesity and asthma seems 
to be more pronounced in women, and obesity have been associated with a specific non-
allergic, female, late-onset phenotype of asthma.145 The stronger association among adult 
women may be related to female sex hormones, although we found stronger associations 
among females also in younger children.   
The mechanisms behind the association between obesity and asthma are likely 
multifactorial and several review studies have discussed these in detail.110, 111 Obesity, 
particularly abdominal fat mass, has been shown to directly affect lung function mechanics 
and compliance of the chest wall resulting in lower expiratory reserve volume and 
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functional residual capacity.146, 147 The association between obesity and lung function was 
investigated in Study III and is discussed more under Section 5.1.3.  
Low-grade inflammation with elevated levels of cytokines and other pro-inflammatory 
factors may also play a role in the obesity-asthma association. The pro-inflammatory 
hormone leptin is positively correlated with obesity and has been found to increase airway 
hyperresponsiveness in mice.111, 148 Elevated serum levels of leptin have also been found in 
asthmatics compared to healthy controls.111, 148 In addition, a metabolic link with asthma 
may be present through insulin resistance, which has been associated with airway 
hyperresponsiveness and airway obstruction in obese children.146, 149  
The obesity-asthma link could also be explained through shared risk factors and 
comorbidity such as gastro-esophageal reflux and sleep-disordered breathing.150 Dietary 
components including antioxidants51, oily fish intake151 and Vitamin D152 have been shown 
to influence the risk of childhood asthma, possibly through anti-inflammatory or 
immunomodulatory mechanisms. Shared genetics and epigenetics could also play a role as 
gene variants in, for example, the adrenoceptor beta 2, tumor necrosis factor and DENN 
Domain containing 1B genes have been associated with both obesity and asthma.146, 153 
Furthermore, specific DNA methylation related to inflammation and metabolic 
dysregulation have been observed in obese asthmatics154. Finally, the gut microbiota may 
also be involved due to its role in immune function.140 
5.1.3 Childhood overweight and lung function 
In Study III, we observed that overweight and obesity in school-age was associated with 
airway obstruction and reduced peripheral airway function up to adolescence. The 
association between overweight and airway obstruction was present both among children 
with and without wheeze at age 16 years, indicating that asthma symptoms may not fully 
explain the observed association. Analyses on change in overweight status between 8 and 
16 years showed that persistent overweight at both 8 and 16 years was associated with 
airway obstruction and increased peripheral airway resistance at age 16 years, whereas no 
association was found for transient overweight.  
Several previous studies118-120, including one recent meta-analysis117, observed an 
association between overweight/obesity and reduced FEV1/FVC, but increased or normal 
FEV1 and FVC in children and adolescents. This had led to the hypothesis that childhood 
obesity may cause airway dysanapsis (asymmetry between airway and lung size). In a 
recent study including six US child cohorts, obesity was found to increase the risk of 
airway dysanapsis in both asthmatics and non-asthmatics, and the association was 
suggested to be, at least partly, unrelated to bronchospasm or airway inflammation.121 
Although dysanapsis was shown to be associated with an increased risk of severe 
exacerbation and corticosteroid use in asthmatics,121 it is debated whether reduced 
FEV1/FVC despite normal FEV1 in obese non-asthmatic children is of clinical relevance or 
part of the normal continuum. The inclusion of IOS as an alternative measure of lung 
function at 16 years in Study III provided additional insight into the physiological 
mechanisms and gave us the possibility to discriminate between the peripheral and central 
airways. We observed strong cross-sectional associations between overweight and obesity 
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and increased peripheral airway resistance and reactance at age 16 years, while results were 
weaker for BMI status at 8 years. This may be explained by the fact that some of the 
overweight and obese children at 8 years had normalized their BMI by 16 years, and 
changes in peripheral airway may have reversed in these subjects. 
Previous evidence regarding the impact of overweight and obesity on peripheral airway 
function is limited. In adults, associations between high BMI and increased IOS parameters 
have been observed in a few small cross-sectional studies.155-157 Two studies on bariatric 
surgery patient158, 159 observed improved small airway resistance in relation to weight loss, 
indicating that the physiological impact of obesity is reversible. In children, conflicting 
results have been reported in the few previous studies on BMI and peripheral airway 
function. In a study of 99 Finish children hospitalized for bronchiolitis in infancy160, current 
BMI at age 5-7 years was associated with increased airway resistance and impedance, 
whereas no association was observed among 518 German 6-year-old children161 or among 
188 Brazilian school-children aged 8-16 years162. The authors of the latter study concluded 
that overweight may be associated with a disproportional lung growth that is independent of 
respiratory disease.162 
The observed inconsistencies between our results and some of the previous studies 
regarding peripheral airway function may be explained by power issues due to small sample 
sizes. In addition, timing and duration of overweight/obesity may be important, which is 
not possible to consider in cross-sectional studies. In the present study, persistent 
overweight at both 8 and 16 years was associated with airway obstruction and reduced 
peripheral airway function at 16 years, while no association was observed for transient 
overweight. Similar results were observed for spirometry outcomes in the Dutch PIAMA 
birth cohort, where persistent high BMI and waist circumference between 8 and 12 years 
were associated with reduced FEV1/FVC at age 12 years.
118 However, no previous 
longitudinal studies have investigated the association between timing and duration of 
overweight in relation to peripheral airway function in children and adolescents.  
Regarding airway inflammation, we found no association between obesity and FeNO in 
Study III. These results are in line with some previous studies in children, which observed 
null or inverse associations between BMI or adiposity and FeNO.114, 115 In addition, we 
analyzed eosinophil and neutrophil cell counts in blood as a measure of systemic 
inflammation, and found that overweight and obesity were associated with increased 
neutrophils, especially in girls. Although we also found slightly higher eosinophils among 
obese girls, the weighted evidence suggest that overweight and obesity primarily are related 
to non-allergic inflammation.  
Obesity seems to impact lung function differently in adults and children. In adults, obesity 
is associated with reduced functional residual capacity and reserve volume, while this has 
not been consistently shown in children.163 Moreover, obesity in adults is associated with a 
restrictive lung function (reduced FEV1 and FVC), while FEV1/FVC is usually not 
influenced.117 Large prospective studies following children from childhood to adulthood 
with detailed assessment of lung function including peripheral airway function are needed 
to further explore the obesity-lung function association during the transition from childhood 
to adulthood. 
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5.1.4 Validity of self-reported height, weight and BMI 
In Study IV, only small differences between web-based self-reported and measured height, 
weight and corresponding BMI were observed. Overall, weight was underreported by 1.1 
kg and height was overreported by 0.5 cm, leading to an underestimation of BMI by 0.5 
kg/m2. The accuracy of self-reported BMI was somewhat lower among girls compared to 
boys, and lower among overweight and obese participants, compared to normal weight 
participants. In contrast, underweight adolescents slightly overreported BMI.  
The results of Study IV are comparable to other validation studies on self-reported height, 
weight and BMI among adolescents. A recent study of 3,379 Estonian school-children aged 
11-15 years164 observed decreasing bias in self-reported values with increasing age. 
Compared to our study, slightly lower underestimation of weight was observed in the 15-
year old age group (0.6 kg in boys and 0.9 kg in girls), while in contrast to our study, boys 
slightly underreported height (0.4 cm). On the other hand, a review including 11 studies of 
US adolescents aged 12-17 years, found slightly larger discrepancies and lower correlations 
between self-reported and measured height and weight in most of the included studies.72 
One recent meta-analysis of 23 studies (including Study IV) assessed the accuracy of self-
reported BMI to detect overweight and obesity in children and adolescents and found a 
pooled sensitivity of 0.76 and a pooled specificity of 0.96.165 The authors concluded that 
self-reported BMI has a high specificity and moderate sensitivity and is a viable alternative 
when measured BMI is not available. However, the validity depended on which reference 
values were used (e.g. IOTF, or national-specific percentiles) as well as study region.165  
In Study IV, we observed decreasing accuracy of self-reported BMI with increasing BMI. 
Only 60% of overweight and 46% of obese were correctly classified, which was somewhat 
lower compared to the above mentioned meta-analysis.165 The trend of decreasing validity 
with increasing BMI is widely observed in the literature,166-168 and may be explained by a 
general tendency of answering questions according to what is socially accepted (i.e. social 
desirability bias). Some suggest that self-reported BMI should be corrected before it is 
used, and have provided equations to do so.167, 169  
Regarding gender differences, our results are in line with several other studies in 
adolescents164, 167, 170 showing slightly higher underreporting of weight and BMI in girls, 
while some found no difference168 or larger underreporting in boys.171 Gender differences 
may be explained by different social norms and ideals in females and males. On the other 
hand, adolescent boys generally grow faster and may be less aware of current weight and 
height, compared to girls. However, we found no differences in the accuracy in relation to 
pubertal status, indicating that growth rate may not be of major importance.   
Except for gender and BMI, no other lifestyle or socioeconomic factor was found to 
influence the validity of self-reported BMI. Previous studies have found conflicting results 
regarding determinant factors for accuracy of self-reported weight and height. In a national 
representative sample of 7,160 US students, screen time and high consumption of fast food 
was associated with overreporting of BMI.166 However, a study in 137 middle school and 
242 high school students observed larger underreporting of weight among participants with 
a high amount of moderate physical activity.168 Additional studies regarding potential 
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prediction factors could be utilized to develop population-specific formulas to correct self-
reported BMI.   
One of the aims of Study IV was to evaluate whether self-reported weight and height could 
be used in future studies in BASME. Based on the results from Study IV, we decided to 
include information on self-reported BMI among adolescents with missing information on 
measured BMI in Study II.    
5.2 METHODOLOGICAL CONSIDERATIONS 
5.2.1 Strengths 
The studies included in the present thesis have several strengths. Using the large 
population-based prospective BAMSE cohort with a high response rate and repeatedly 
collected high-quality data from birth to 16 years is a major strength. Weight and height 
were objectively measured for the majority of participants and objective outcome 
information for lung function and allergic sensitization were analyzed in addition to 
questionnaire-based information on allergic disease.  
5.2.2 Random errors 
The reliability of an epidemiological study depends on the amount of systematic (described 
in 5.2.3) and random error. Random error arises from sampling variability related to the 
study size as well as the prevalence of exposure and outcome (if categorical). Low amount 
of random error (i.e. high precision) means that the results would be reproduced if the study 
was repeated under the exact same conditions. The amount of statistical variability is 
indicated by the width of the confidence intervals. In a small study with a rare exposure or 
outcome, random error is higher (wider confidence intervals) compared to a large study 
with a more common exposure or outcome (more narrow confidence intervals).  
Considering the relatively common outcomes, the sample sizes in the present studies were 
comparatively large (n >2,800 in Studies I-III and n=1,698 in Study IV), with rather 
narrow confidence intervals. Lower precision was present in stratified and sub-analyses, 
such as the analysis on overweight in combination with wheeze in Study III. Likewise, for 
some exposure categories such as underweight (mothers in Study I and children in Study 
III), there were few subjects, resulting in lower precision.  
Another concept related to random error is multiple testing. In the present studies, a 
substantial number of analyses were performed with several outcomes and different 
exposure models being evaluated. A large number of analyses increases the risk of chance 
findings, which is incorrect rejection of the null hypothesis (type I error). However, specific 
pre-defined hypotheses were tested and the analyses were not independent. Adjusting for 
multiple comparisons may in this case be too conservative and increases the risk of type II 
error (the incorrect decision to not reject the null hypothesis). In epidemiological studies, 
there is always a trade-off between the risk of chance findings, which is set by the 
significance level, and the ability to detect a true association.172 However, the significance 
level is an arbitrary value which one may use as a guide rather than a definite cut-off to 
interpret the results. In the present thesis, the main findings are, in addition to their 
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statistical significance, in line with previous research and therefore unlikely to solely be 
explained by chance.  
5.2.3 Systematic errors 
The amount of systematic error reflect to what extent the study measure what it is supposed 
to measure. In contrast to random errors, systematic errors are not related to study size or 
prevalence of exposure or outcome. Systematic errors can be divided into selection bias, 
misclassification and confounding. 
5.2.3.1 Selection bias 
Selection bias occurs when study participants are not representative of the target 
population. Selection bias may affect the prevalence, or more seriously, the observed 
association between exposure and outcome. The short questionnaire that was sent out to 
non-participants and excluded children in BAMSE showed that there were no major 
differences between the final cohort and non-participants or excluded children regarding 
known risk factors for allergic disease, except for parental smoking which was less 
common in the study population. Parental BMI was not assessed at this time point, but 
maternal BMI in our study population was similar to the average BMI in early pregnancy 
among all women in Stockholm during the study period (22.9 kg/m2 compared to 23.3 
kg/m2). Selection bias will only influence the estimated association between exposure and 
outcome if the association differs between included and non-included subjects. Such a bias 
is generally less likely to be present at baseline in a cohort study as participants are 
included before disease onset.  
During follow-up, participation rate might differ in relation to exposure or outcome, which 
may introduce more serious selection bias. Fortunately, the BAMSE cohort has a low drop-
out rate (78% of the original cohort answered the 16-year questionnaire), which reduces the 
risk of selection bias. For example, maternal BMI in early pregnancy was 22.9 kg/m2 
among those answering the 16-year questionnaire, compared to 23.1 kg/m2 among those 
that did not answer this questionnaire. In addition, only small differences were observed 
between each study population and the original cohort, suggesting that no major selection 
bias was introduced when defining the study populations. Despite this, selection bias cannot 
be completely ruled out. For example, children who develop extreme obesity may drop-out 
to a higher extent or do not give permission to collect data from the school health care 
records compared to moderately obese children. If these children also have a higher risk of 
asthma or reduced lung function, the association between obesity and asthma/lung function 
will be underestimated. 
5.2.3.2 Misclassification 
Misclassification (also referred to as information bias) occurs when exposure or outcome 
are measured or classified incorrectly. Non-differential misclassification refers to 
misclassification that is equally distributed in relation to exposure or outcome. Under most 
circumstances, non-differential misclassification leads to a dilution of the association, 
whereas differential misclassification can cause an overestimation or underestimation of the 
association.  
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In the present studies, maternal and childhood BMI were measured for the majority of 
participants, which limits misclassification compared to self-reports. Small measurement 
errors, for example measuring weight with clothes on, are however relevant for the 
validation study (Study IV) and may have explained some of the observed differences 
between reported and measured weight. In Study I, maternal BMI was collected during 
pregnancy, i.e. before children were born and any allergic symptoms appeared. Any 
misclassification of maternal BMI should therefore be non-differential in relation to allergic 
outcomes in the offspring and may only have led to a dilution of the association. For the 
majority of participants, maternal BMI was assessed in the first trimester of pregnancy 
where median weight gain has been shown to be minimal in normal weight, overweight and 
obese women.173  
BMI is a quick and simple measure of overweight/obesity that has been shown to be highly 
specific and moderately sensitive to identify children174 and adults175 with excessive fat 
mass. However, BMI cannot differentiate between lean and adipose tissue on an individual 
level, and if we believe that adiposity and not BMI per se is the important risk factor, some 
participants (children or mothers) may have been misclassified with regards to BMI status. 
Participants with low proportion of adiposity but high BMI (e.g. very athletic) may have 
been misclassified as overweight (less likely due to the high specificity), whereas the 
opposite may have occurred among participants with high proportion of adiposity but 
normal BMI (more likely due to the moderate sensitivity). Although asthma has been found 
to be somewhat more common among athletes, this is mainly seen among endurance 
athletes for example skiers where BMI generally is not elevated.176 Any misclassification of 
overweight is therefore probably non-differential in relation to outcome and may only lead 
to a dilution of the observed associations.  
The outcomes asthma, rhinitis and eczema were mostly based on parental questionnaire 
reports of validated and widely used questions. However, some misclassification of self-
reported allergic outcomes is difficult to avoid as parents may interpret questions 
differently or may not accurately remember their children’s symptoms or medications. For 
example, parents with allergic disease themselves may be more aware of allergic symptoms 
in their child, compared to non-allergic parents. Therefore, in Study I, parental allergic 
disease was evaluated as a potential effect modifier, but no significant differences in the 
results were observed among children with or without parental allergic disease.  
Another potential source of misclassification is over-reporting of respiratory symptoms 
among overweight/obese, as breathing difficulties during exercise may be misinterpreted as 
asthmatic symptoms.150 Such a bias would lead to an overestimation of the association 
between asthma and BMI in children, but is difficult to estimate in the present study. In 
order to minimize the risk of misclassification of non-asthmatic symptoms as asthma, rather 
strict definitions of asthma with a combination of repeated symptoms and/or single 
symptoms and medications were used in the present studies. However, defining asthma in 
children is challenging as no gold standard exists and there is a trade-off between missing 
cases using a too strict definition (high specificity, but lower sensitivity) and the risk of 
classifying non-cases as cases using a too inclusive definition (high sensitivity but lower 
specificity).  
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The risk of misclassification is lower for the objectively measured outcomes lung function, 
allergic sensitization and inflammation. Lung function was measured by trained nurses and 
checked for quality control using ATS/ERS guidelines. Although different spirometers 
were used at 8 and 16 years, any systematic differences should not be related to BMI status 
and may only lead to a dilution of the observed association. The cut-off 0.35 kUA/L for 
sensitization is a technical cut-off that is widely used in the literature.    
Finally, the time between the questionnaire and the clinical investigation may have 
introduced bias. Especially in the validation study (Study IV), the time period between the 
questionnaire and the measurements may have led to some small but actual changes in 
height and weight. In order to avoid bias, we restricted the study population to adolescents 
with up to 8 weeks between self-reported and measured values. 
5.2.3.3 Confounding 
Confounding occurs when there is a factor outside the studied exposure that affects the 
outcome (increase or decrease the risk) and is associated with the exposure, but not an 
effect of the outcome or exposure.172 Confounding is sometimes referred to as a mixing of 
effects,172 meaning that the observed association is due to another factor than the 
investigated exposure. Methods such as restriction, stratification or regression modelling 
can be used to control for confounding. Given no other errors, perfect confounding control 
will give the causal effect of the exposure on the outcome. Uncontrolled confounding will 
result in an overestimate, underestimate or even a reverse of the true association under 
extreme conditions. 
In the BAMSE study, extensive exposure information have been collected, which allowed 
for evaluation of many potentially important confounding factors, including parental 
smoking, socioeconomic status and allergic heredity. Confounders were selected based on 
a-priori knowledge or testing and controlled for by regression modelling. Potential 
mediators were handled separately, and included in separate models only to investigate 
whether there were any direct associations that were independent of the mediators. Another 
increasingly used method to select covariates is to use a directed acyclic graph (DAG). A 
DAG is a visual presentation of causal associations between variables that can be used to 
determine which factors to control for in order to estimate the causal association between a 
specific exposure and outcome. Within the present project, DAGs were explored but not 
used as we encountered challenges with drawing the complex associations between all 
factors related to BMI and allergic disease. However with more training and experience, I 
believe that the DAGs could be a useful method to consider in future projects.    
Although a large number of variables were considered as potential confounders in the 
present studies, unmeasured or residual confounding may still be present. Socioeconomic 
status may be an important confounder in the association between BMI status and allergic 
disease as it has previously been associated with both allergic disease177 and BMI status.76 
Socioeconomic status is a complex variable that can be defined by occupation, income or 
education. In the present study, socioeconomic status was defined based on parental 
occupation which may not represent all aspects of this concept. However, other variables 
such as parental age, smoking, maternal BMI and breastfeeding are associated with 
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socioeconomic status and may together capture a large part of what is represented by this 
variable. 
Moreover, dietary factors and physical activity could potentially confound the associations 
in the present studies, as certain dietary factors including fruit, vegetables and fish have 
been associated with lower risk of asthma symptoms,178 while sedentary behavior may 
increase the risk.179 In the present project, we lacked information on maternal diet and 
physical activity, which may be important for the association between maternal BMI and 
asthma in Study I. However, adjusting for oily fish intake and physical activity at 16 years 
did not influence the association between asthma phenotypes and BMI in Study II. In 
addition, physical activity at age 16 years did not influence the results between BMI and 
lung function in Study III, and was not found to be a predictor of validity of self-reported 
BMI in Study IV.  
5.2.4 Generalizability 
The population-based design of the BAMSE study increase generalizability. The BAMSE 
study included 75% of all eligible subjects and participants did not differ from non-
participants and excluded children, except for the prevalence of parental smoking which 
was somewhat lower in the included cohort. However, one of the exclusion criteria of the 
BAMSE study was insufficient knowledge of the Swedish language which likely led to 
fewer parents of non-Swedish origin. At the same time, we have no reason to assume that 
the underlying biological mechanisms would differ across ethnicity, and therefore we still 
think that the results could be generalizable to other populations.  
For the validity of self-reported weight, height and BMI, we do belive that the results could 
differ between populations as validity may depend on specific characteristics such as age, 
ethnicity and sociodemographic factors.    
  
  45 
6 CONCLUSIONS 
 
Based on the results from this thesis and the current scientific literature, it may be 
concluded that overweight and obesity are associated with asthma and evidence of airway 
obstruction in children and adolescents. From Studies I-IV, the following specific 
conclusions can be drawn: 
I. Maternal BMI may increase the risk of asthma in the offspring up to adolescence, 
however, the association may partly be explained by overweight in the offspring. 
Maternal BMI does not seem to be associated with rhinitis, eczema or allergic 
sensitization in the offspring, indicating that non-allergic mechanisms are 
predominating.  
II. Asthma, in particular persistent asthma throughout childhood, is associated with 
high BMI development and increased risk of overweight among girls, whereas the 
potential association between asthma and BMI is more uncertain among boys. 
Altogether, the current evidence indicates that the temporal direction of the 
association between overweight and asthma may be bidirectional.   
III. Overweight and obesity in school-age and adolescence appear to be associated with 
airway obstruction up to adolescence, and also involving the peripheral airways. 
IV. Web-based self-reported BMI can be used as a valid, quick and cost-effective 
alternative to measured BMI among Swedish adolescents. However, the accuracy 
declines with increasing BMI.  
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7 FUTURE PERSPECTIVES 
 
Allergic diseases affect a large proportion of the population and contribute to a substantial 
burden for the affected individuals, families and society. Identifying modifiable risk factors, 
such as overweight and obesity, are necessary for successful prevention of allergic diseases. 
The studies in this thesis add to the body of evidence suggesting that maternal and 
childhood overweight is associated with asthma and signs of airway obstruction in 
childhood and adolescence. The validation study may be helpful for future research with 
self-reported weight and height, however, validation studies need to be continuously 
performed on the specific populations where they are intended for use. 
To date, few intervention studies on weight-loss in relation to asthma and lung function 
have been performed180-182, and there is a need for large randomized trials to be able to 
provide evidence-based advice and treatments. These studies could investigate 1) whether 
weight-loss improves asthma symptoms/severity and lung function and 2) which type of 
weight-loss intervention is most effective for asthma control and lung function. Preferable, 
detailed assessment of body composition should be performed to provide more insight into 
the underlying factors and to avoid misclassification (in particular during physical activity 
interventions, where adiposity may decrease although BMI remains unchanged).  
In addition, only a few studies have analyzed the risk of incident obesity in asthmatics and 
future studies should focus more on the potential bidirectional association between obesity 
and asthma across the life course. These studies could also investigate whether there are 
particular groups of asthmatics (e.g. regarding gender, allergic status or activity level) who 
have an increased risk of obesity, and should be targeted for prevention.  
Finally, the underlying factors for an association between maternal obesity and asthma in 
the offspring need to be better understood. More research on the role of lifestyle factors 
during pregnancy such as diet and physical activity, as well as gestational weight gain, 
would provide evidence to strengthen the advice given to pregnant women.   
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8  POPULÄRVETENSKAPLIG SAMMANFATTNING 
Allergiska sjukdomar såsom astma, hösnuva och eksem debuterar ofta i barndomen och 
förekommer hos ca 30-40% av befolkningen. Förekomsten av övervikt och allergiska 
sjukdomar har ökat parallellt under de senaste decennierna, och flera studier har indikerat 
att barn med övervikt och fetma har en ökad risk att utveckla astma. Det övergripande 
syftet med denna avhandling var att undersöka sambanden mellan övervikt (hos modern 
och barnet) och allergiska sjukdomar samt lungfunktion under barndomen upp till tonåren. 
Dessutom undersökte vi tillförlitligheten av självrapporterad längd, vikt och motsvarande 
body mass index (BMI) vid 16 års ålder. Avhandlingen innefattar fyra delarbeten vilka alla 
baseras på den svenska BAMSE-studien där drygt 4000 barn följts från födseln upp till 16 
års ålder. 
I det första delarbetet undersökte vi sambandet mellan moderns BMI i tidig graviditet och 
allergiska sjukdomar samt allergisk sensibilisering hos barnet upp till 16 års ålder. 
Information om moderns BMI erhölls från det medicinska födelseregistret där vikt och 
längd registrerats vid första besöket hos mödrahälsovården runt graviditetsvecka 10. 
Allergisk sjukdom hos barnet samlades in via upprepade frågeformulär med fokus på 
symptom och medicinering, medan sensibilisering definierades utifrån uppmätta 
allergiantikroppar mot luftburna allergen i blod. Resultaten visade att mammans BMI i tidig 
graviditet var kopplat till en ökad risk för astma, men inte hösnuva, eksem eller allergisk 
sensibilisering hos barnet upp till 16 års ålder. Starkast samband sågs för bestående astma, 
s.k. persistent astma, medan ingen ökad risk observerades för tidig övergående astma. 
Fortsatta analyser visade att det framförallt var fetma hos modern som bidrog till en ökad 
risk för astma, medan inget signifikant samband sågs för övervikt. Dock fann vi att barnets 
egen viktstatus delvis kunde förklara sambandet mellan moderns BMI och astma hos 
barnet. 
I delarbete två analyserade vi BMI-utveckling under barndomen samt risken för övervikt i 
förhållande till astma. Barnets BMI mättes vid kliniska undersökningar och samlades in 
från skol- och barnhälsovårdsjournaler. Vi de senare åldrarna kompletterades dessa data 
med självrapporterad vikt och längd för de ungdomar som saknade uppmätta värden. 
Resultaten visade att flickor med bestående astma hade högre BMI och en ökad risk för 
övervikt under barndomen jämfört med flickor utan astma. Flickor med tidig övergående 
astma hade en ökad risk för övervikt mellan 4-8 års ålder, medan flickor med senare 
debuterande astma hade en tendens till ökad risk för övervikt under tonåren. Hos pojkar 
sågs betydligt mindre skillnader i BMI mellan barn med och utan astma och inget tydligt 
samband mellan astma och övervikt observerades. 
I det tredje delarbetet undersökte vi sambandet mellan övervikt och lungfunktion från 
skolåldern till tonåren. Lungfunktion mättes med två olika metoder vilket gav möjlighet att 
analysera både de centrala och de små luftvägarna. Resultaten visade att övervikt och fetma 
vid 8 års ålder var kopplat till större lungvolymer men en relativ lungfunktionsnedsättning 
(uppmätt som lägre FEV1/FVC kvot) samt ett ökat luftvägsmotstånd i de små luftvägarna. 
Lägst FEV1/FVC sågs hos dem med övervikt vid både 8 och 16 år, medan inget signifikant 
samband sågs hos dem som utvecklat normalvikt vid 16 års ålder.  
  49 
I delarbete fyra jämförde vi självrapporterad och uppmätt vikt, längd och motsvarande 
BMI vid 16 års ålder. Resultaten visade att självrapporterad vikt och längd överlag var 
starkt korrelerade. I genomsnitt var självrapporterad vikt 1,1 kg lägre än uppmätt, medan 
självrapporterad längd var 0,5 cm högre än uppmätt, vilket ledde till en underskattning av 
BMI med i genomsnitt 0,5 kg/m2. Tillförlitligheten av självrapporterad BMI var något lägre 
bland flickor jämfört med pojkar, samt bland ungdomar med övervikt och fetma jämfört 
med normalvikt. 
Sammanfattningsvis tyder våra resultat på att moderns och barnets viktstatus är kopplade 
till astma och nedsatt lungfunktion under barndomen och tonåren. Sambandet mellan 
moderns BMI och astma hos barnet verkar till viss del kunna förklaras av barnets egen 
viktstatus. Att vi inte ser någon koppling till eksem och hösnuva tyder på att de 
bakomliggande mekanismerna främst innefattar icke-allergiska faktorer, till exempel 
påverkad lungfunktion.  
Slutligen kan vi konstatera att självrapporterat BMI kan användas som ett snabbt och 
kostnadseffektivt alternativ till uppmätt BMI hos svenska ungdomar. Dock är 
tillförlitligheten lägre hos ungdomar med övervikt och fetma, jämfört med normalviktiga 
ungdomar. 
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11  APPENDIX 
 
Table 11.1. Definition of covariates 
Variable Source 
of data 
Definition Study 
Sex Q0 Biological sex of participant (female or male) I, II1, III, IV1,2 
Birth weight MBR Birth weight of the child (grams) I3 , III3 
Gestational age MBR Gestational age of the child at birth (weeks) II, III3 
Mode of delivery MBR Birth mode of delivery (vaginal or caesarian section)  I3 
Newborn 
respiratory 
diagnosis 
MBR Hypoxia, asphyxia, respiratory distress syndrome and 
other respiratory conditions of the fetus or newborn (ICD 
9: 768-770) 
I3 
Maternal age  Q0 Maternal age at the child’s birth (years) I 
Maternal BMI MBR Maternal body mass index in early pregnancy II, III3 
Older siblings MBR Maternal parity ≥1 at the time of birth I 
Parental ethnicity Q8 Any parent born outside of Scandinavia IV2 
Parental allergic 
disease 
Q0 Mother or father reporting doctor’s diagnosis of asthma 
in combination with asthma medication or doctor’s 
diagnosis of hay fever in combination with allergy to 
furred pets- or pollen   
I, II, III3 
Maternal smoking  Q0 The mother smoked at least one cigarette per day at any 
time during pregnancy or during the child’s infancy 
I, II, III3 
Socioeconomic 
status 
Q0 Parental occupation categorized into three (blue collar 
worker, white collar worker or other) or six groups 
(unskilled blue-collar workers, skilled blue collar workers, 
low level white collar workers, intermediate level white 
collar workers, high level white collar workers and other 
(student) according to Statistics Sweden “Socioeconomic 
division (SEI); Reports on Statistical Coordination 
1982:4”) with dominance order  
I, II, III3, IV2 
Breastfeeding Q1 Exclusive breastfeeding (≥4 months or <4 months) I3, II, III3 
Pubertal status cQ12, 
cQ16 
Pubertal status categorized into five categories: pre-
pubertal, early pubertal, mid-pubertal, late pubertal or 
post-pubertal according to a pubertal development scale 
based on questions on body hair development, linear 
growth spurt, and pubic hair growth (both boys and girls); 
voice change and beard growth (boys only); and breast 
development and menarche (girls only)183 
II3, III3, IV2  
Physical activity cQ12, 
cQ16 
Self-reported amount of vigorous physical activity 
(hours/week) such as lifting heavy weights, aerobics, or 
high speed bicycling in the last 12 months. Mean of 
summer and winter season was calculated  
II3, III3 IV2 
Fatty fish intake cQ16 Intake of salmon, herring or mackerel (<1/week or 
≥1/week) 
II3 
Sedentary time cQ16 Time (hours/day) outside of school spent on watching TV, 
computer use, video games or reading.  
IV2 
Sleep cQ16 Average sleep per night (<8 hours or ≥8 hours) IV2 
Fruit and vegetable 
consumption 
cQ16 Intake of fruit and vegetables (every day or less than 
every day) 
IV2 
Tobacco use cQ16 Regular or irregular use of cigarettes or snuff IV2 
Smoking cQ16 Regular or irregular smoking at 16 years  III3 
  67 
Self-perceived 
health 
cQ16 Self-rated health (completely healthy or fairly 
healthy/not very healthy) 
IV2 
1used for stratification only 
2evaluated in prediction models only 
3evaluated as a potential mediator or confounder in sensitivity analyses only 
MBR: medical birth register, Q: questionnaire, cQ: child’s questionnaire 
 
